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ABSTRACT
Influenza is an often lethal infection for elderly populations. Here we determine how aging effects
humoral, CD4+ T cell, splenic stromal cell and lymph node stromal cell response to influenza
infection. T follicular helper (T FH) cell responses are essential for generation of protective
humoral immunity during influenza infection. Aged mice have smaller germinal centers, with
fewer germinal center B cells resulting in decreased influenza specific IgG. Influenza specific
TFH cells are generated in similar numbers in young and aged animals during infection, but
TFH cells from aged mice fail to reach full maturity, have reduced expression of costimulatory
molecules and elevated production of IL-10 and IFNγ, which potentially impairs interaction with
cognate B cells. Also, more influenza specific T cells in aged mice have a regulatory phenotype
and adoptive transfer studies with young T cells demonstrated that TGF-β1 in the aged splenic
environment may drive increased regulatory T cell accumulation. Another component of the
splenic environment that is altered with age are the stromal cell subset, fibroblastic reticular
cells (FRC). FRCs are located in the T cell zone of the splenic white pulp and produce
homeostatic chemokines which direct cells into the T cell zone. We found that aged spleens
have fewer FRCs and lower homeostatic chemokine concentration than young, which may
delay recruitment of T cells. Unlike spleens, young and aged lymph nodes had similar numbers
of FRCs at homeostasis, but aged lymph node FRCs took longer to expand in number due to
decreased proliferation after infection. Aged lymph nodes also had reduced homeostatic
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chemokine concentrations. From adoptive transfer studies, we went on to determine that young
influenza specific CD8+ T cells have reduced proliferation in aged compared to young lymph
nodes after infection. The mechanisms involved are not clear since there are no age-related
differences in lymph node FRC suppressive capacity. Collectively these studies expand our
understanding of how aging impacts the immune response to influenza infection.
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CHAPTER 1
INTRODUCTION
An Aging World
Simplistically, aging can be defined as a time-dependent functional decline that influences most
living organisms1. Despite this simple definition, aging is a complex, multifactorial process that is
poorly understood. Why we age, when we start aging, and why aging is biologically important, are
three central and almost philosophical questions that the field is working to address. Regardless
of these uncertainties, it is clear that the human species is aging. The World Health Organization
estimates that the global population over the age of 60 will double to a staggering two billion
people by the year 2050 and the population over the age of 80 will quadruple to 395 million people
in the same time peroid.2 An unprecedented demographic shift is also predicted to occur in this
time period. The population over the age of 60 will outnumber the population under the age of
five for the first time in human history2. Aging is the biggest risk factor for the development of
numerous chronic diseases such as cancer, heart disease, stroke, dementia, and osteoarthritis3.
This increase in the size of the elderly population and their predisposition to multiple diseases will
place immense financial burdens on health care systems which are currently ill adept to treat such
populations4.

Influenza and the elderly
Along with chronic diseases, aging predisposes the elderly to increased susceptibility to infectious
agents. Influenza infection is a major problem for the elderly, ranking in the top 15 causes of death
for persons over the age of 75 in the United States5. It is estimated that 90% of influenza related
deaths are in patients above the age of 656,7, resulting in an annual death toll averaging around
5,500 patients in the U.S.A. alone8. Not surprisingly, the population over the age of 65 has the
highest rate of hospitalizations associated with influenza. The CDC estimates that 321.1 per
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100,000 patients over the age of 65 were hospitalized during the 2015/2016 influenza season, a
striking eight times higher incidence than the 18-49 age group (39.9 / 100,000)9.

Despite high rates of seasonal influenza vaccination10, efficacy remains low in the elderly
populations11, emphasizing the importance of developing new therapeutics to protect this at risk
population. In order to develop new treatments for the elderly, it is imperative to understand what
is going wrong in the aged immune response to influenza infection, which is the central focus of
this thesis.

Influenza virus
Influenza virus is the pathogenic agent responsible for influenza infection. Influenza infection can
manifest as mild to severe illness with symptoms often including fever, chills, fatigue, body aches,
runny nose, and cough12. As discussed above, complications often arise during infection in the
elderly, in many cases leading to death. Influenza viruses are negative sense, single stranded
RNA viruses belonging to the family Orthomyxoviridae. There are three main types of influenza
viruses A, B, and C. Influenza A is the most common influenza virus associated with human
infections13. Influenza A virus is a roughly spherical enveloped virus, ranging from 80-100nm in
diameter14. It has eight segments of RNA which encode 11 proteins15. The viral envelope contains
hemagglutinin (HA) which binds to sialic acid on epithelial cells of the upper and lower respiratory
track to mediate endocytosis into the host cells16. Neuraminidase (NA) is an envelope
glycoprotein, which is important for the release of the viral particles from the host cell via cleavage
of sialic acid17. The last envelope glycoprotein is matrix protein M2 (M2) which is an ion channel
functioning in maintenance of viral pH18. The internal portion of the viral lipid envelope is coated
by matrix protein 1 (M1), which provides rigidity and strength and functions in the export of viral
RNA with nuclear export protein (NEP)19. In the viral core, RNA is complexed with structural
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nucleoprotein (NP), and polymerase subunits: polymerase PB1, polymerase PB2, Acid
polymerase (PA)20. The last protein encoded by influenza A is Non-structural protein 1 (NS1),
which is an interferon antagonist21,22. Many of these proteins are recognized by different parts of
the immune system, which will be discussed subsequently. Aging has a dramatic impact on
immune system composition, function, and response to influenza infection, which is discussed in
detail below.

Age related changes in primary lymphoid organs
Both primary lymphoid organs, the thymus and the bone marrow, experience age related
alterations. The thymus is a primary lymphoid organ important for the development and
maturation of T cells23. With increasing age, the thymus undergoes a process known as involution.
The thymic epithelial space, composed of the medulla and cortex, where T cell maturation occurs,
decreases in cellularity and increases in adiposity during involution24. This process was thought
to begin at puberty, but it is now clear that involution begins much earlier, starting at one year of
age in humans25. Thymic involution results in the decreased output of naïve T cells into the
periphery26–28. Thymic involution also impacts the development of T cells, results in decreased
TCR diversity in aged CD8+ T cells29. The aged bone marrow also contributes to changes in T
cells with age.

In the aged bone marrow, hematopoietic stem cells (HSC) increase in number, but are functionally
impaired and have decreased regenerative potential30–34. HSCs also shift toward the production
of common myeloid progenitor cells away from common lymphoid progenitors, further decreasing
the production of cells of the lymphoid lineage30. Age related alterations in primary lymphoid
organs are upstream to the problems that arise in the adaptive immune cells.
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Impaired humoral immune response to influenza infection with age
Humoral immunity is an important component of the adaptive immune response to influenza35. B
cell deficient, µMT mice, are 100 times more susceptible to influenza than wild type mice35.
Antibody responses to HA, NA and NP provide protection against the virus. Anti-HA antibodies
neutralize the virus, by preventing entry into the host cell36,37. SCID mice, which lack functional T
cells and B cells, are highly susceptible to influenza infection, but neutralizing monocolonal IgG
antibodies directed against HA alone can provide protection from an otherwise lethal influenza
infection38. Anti-HA and anti-NA antibodies enhance virus up take via Fc mediated phagocytosis
and promote killing of virally infected cells through antibody dependent cell mediated cytotoxicity
(ADCC)39. Antibodies directed against the internal influenza protein NP have also been shown to
provide protection against influenza, through a mechanism that remains to be elucidated40–42. Of
note, antibody against influenza virus does not need to be neutralizing to be protective as in the
case of anti-NP42,43.

Changes in B cells contribute to the increased susceptibility of the elderly to influenza. B cells
experience age related declines, starting with changes in the bone marrow. In the aged bone
marrow there are fewer precursor B cells, including pre-B, which contribute to decreased output
of naive B cells into the preiphery44–46. Despite the decreased output of B cells, the number of
follicular B cells remains consistent with age as a result of decreased turnover of B cells in the
aged environment47,48. B cells also exhibit functional impairments with age including declining B
cell receptor (BCR) diversity in mice49–52 and some elderly subjects53. Furthermore, aged B cells
experience impaired class switch recombination, in part due to decreased expression of the
transcription factor E47 and the enzyme activation induced cytidine deaminase (AID)54,55. Finally,
production of high affinity, class switched antibodies to newly encountered pathogens like
influenza is reduced with age56–58. Class switching and affinity maturation occur in germinal
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centers within secondary lymphoid organs59,60 and, not surprisingly, with age germinal center
formation is reduced and the germinal centers that do develop are small and disorganized61.
These changes to antibody and germinal center responses are in part due to the described B cell
intrinsic defects along with age related changes in CD4+ T cell help.

T cell responses to influenza infection
T cells are important for protection against influenza infection. The most immunodominant
epitopes in influenza for both CD4+ and CD8+ T cells can be found in the NP molecule62–64.
Influenza specific CD8+ T cells alone, but not CD4+ T cells, can promote recovery of B cell
deficient mice from influenza infection35. CD8+ T cells kill virally infected cells by exocytosis of
granules containing granzymes and perforin65,66. CD4+ T cells in combination with antibody can
also protect B cell deficient mice from influenza67. Studies with CD4+ T cell depleted mice have
shown that CD4+ T cells are not required for the clearance of influenza virus 68,69. CD4+ T cells
are thought to contribute to the immune response to influenza infection by providing “help” to both
B cells and CD8+ T cells. CD4+ T cells in particular are classically considered helpers, although
we have recently reported the first case of IL-21 producing CD8+ “helper” T cells70. CD4+ T cells
help sustain CD8+ T cell responses by production of Type 1 cytokines IFN-γ, IL-2 and TNF-α71.
CD4+ T cells also “help” B cells by aiding in the production of IgG antibodies against influenza
created in germinal centers 72.

Germinal centers are highly organized structures in B cell follicles where high affinity antibody
responses are generated59. GC formation is dependent on the differentiation of naïve CD4+ T
cells into mature germinal center T follicular helper cells (TFH) and their resulting functions60,73–75.
The maturation of naïve CD4+ T cells into mature germinal center T FH is a well characterized
spatiotemporally regulated process. The first step of TFH development occurs after contact with
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dendritic cells in a B cell independent manner76. This step results in the formation of pre-TFH which
express the B cell follicle homing receptor CXCR5, transcription factor Bcl6, ICOS, PD-1 and start
to produce IL-4 and IL-2177. Upregulation of CXCR5 and down regulation of CCR7 and PSGL1
promote pre-TFH migration from the border of the T cell zone and B cell zone into the B cell follicle
in response to follicular CXCL1378–81. This stage depends on follicular B cell engagement of ICOSL with ICOS on pre-TFH, which induces pseudopod formation and migration of pre-TFH into the B
cell follicle82. The exact signals that induce the maturation of pre-TFH to germinal center TFH are
not yet well established, but SAP83 and TCR signal strength appear to be important84,85. Germinal
center TFH function in a variety of ways including production of cytokines such as IL-4 and IL-21,
which aid in class switch recombination and promote B cell/plasma cell differentiation and
survival86–88. Germinal center TFH also express molecules important for promoting B cell functions
such as OX40, Ly108 and SLAM89. Germinal center TFH are often identified by their expression
of TFH markers PD-1, CXCR5 and GL7, a sialylated glycan90.

Germinal center responses are controlled by a recently defined subset of CD4+ T cells, called T
follicular regulatory cells91–93. T follicular regulatory cells (TFR) are derived from thymic regulatory
T cells and are identified by their expression of CD4, PD-1, CXCR5, Bcl6, and Foxp392. One way
TFR inhibit TFH and B cell function is suppression of responses via PD-194. Sage et al recently
characterized how TFR cells alter metabolism in TFH and B cells to control their functionality95. Yet
it remains unclear how aging impacts TFH and TFR development. This will be addressed in chapter
two of this thesis.

Impact of aging on CD4+ T cell responses
With age there is a shift in the CD4+ T cell pool away from the naïve population toward cells of
the memory phenotype96–99. Like B cells, the upstream changes in primary lymphoid organs
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decrease the output of naïve T cells into the periphery100,101. Changes in homeostasis, including
decreased expression of pro-apoptotic factor Bim, increase the lifespan of naïve CD4+ T cells in
the periphery102,103. While newly generated CD4+ T cells from aged mice function as well as young
CD4+ T cells, defects in function arise with increasing time in the periphery, suggesting that the
aged environment has a negative impact on T cell function100,103,104. Importantly, CD4+ T cells
experience many intrinsic defects that arise with age and time in the aged circulation. Aged naive
CD4+ T cells exhibit reduced proliferation and production of IL-2 in response to peptide
stimulation105. Aged CD4+ T cells also experience defective immune synapse formation106,107,
reduced TCR signaling, including reduction in ZAP-70108 and Raf-1 activation109. Unlike B cells,
which have reduced BCR diversity49, CD4 + T cells do not appear to have reduced TCR repertoire
diversity with age110. Influenza NP specific CD4+ T cell precursor frequency is similar in young
and aged mice110. In contrast, CD8+ T cells have altered Vβ usage and reduced TCR diversity,
which correlates with impaired response to influenza infection29,111. There are also shifts in CD8+
T cell immunodominance, due to holes in the T cell repertoire, resulting in fewer NP specific CD8+
T cells in aged mice29,111. Finally, during influenza infection, the appearance of both CD4+ and
CD8+ influenza specific NP T cells in aged compared to young lungs is delayed29,110. This may
be due to differences in precursor frequency along with changes in priming and may contribute to
delayed viral clearance in aged mice after influenza41,112,113.

Impaired T cell and B cell responses with age may be linked to changes in Foxp3+ regulatory T
cells (Tregs). Aged mice have been shown to have increased numbers of Tregs in secondary
lymphoid organs but not in the peripheral blood114–118. This increase in Tregs could lead to delayed
immune responses found in aged mice and humans. It is unclear how aging impacts Treg function,
but several studies have demonstrated that aged T regs maintain their ability to suppress T cell
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proliferation in vitro119,120. How aging impacts the Treg response to influenza infection is explored
in chapter two of this thesis.

Impaired humoral responses and decreased germinal center (GC) formation are well established
age related immune function changes61,121. We have also shown that young CD4+ T cells
transferred into aged CD4 KO mice can overcome B cell mediated defects122, suggesting that age
related alterations in CD4+ T cells contribute to B cell problems with age. Our previous studies
suggest that the aged splenic environment inhibits the differentiation of young CD4+ T cells into
TFH123. Yet it remains to be determined how aging impacts TFH development and function. Chapter
two of this thesis addresses this question by characterizing how aging impacts the antigen specific
TFH response to influenza infection. Our hypothesis predicts that age related changes in TFH
development and function may be contributing factors to the deceased humoral response in age
mice to influenza infection. This chapter also describes how aging impacts the development of
TFR and how these changes may contribute to impaired humoral responses with age. In chapters
three and four we explore the impact of the aged secondary lymphoid organ environment on
impaired immunity to influenza infection, with a focus on stromal cell biology.

Secondary lymphoid stromal cells: an underlying contributor to immunosenescence?
Stromal cells are non-hematopoietic cells in secondary lymphoid organs (lymph nodes, spleen)
that were once considered purely structural in nature124. During the past decade this simplistic
view has been overturned by an insurgence of research revealing the integral role of stroma in
maintaining and controlling immune cell function. While much of aging immunology research has
been focused heavily upon determining cell intrinsic defects in adaptive and innate immune cells,
the contribution of secondary lymphoid stromal cells to age-related defects in immunity are just
beginning to become unraveled123,125,126.
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Adoptive transfer studies have been the key to dissecting the impact of the aged “environment”
on CD4+ and CD8+ T cell responses. By transferring young OTII CD4+ T cells intravenously (IV)
into young or aged hosts immunized with OVA and alum adjuvant, Lefevbre et al. showed that
young T cells have delayed entry (18 hours after transfer), proliferation, expansion and
differentiation (into TFH) in aged spleens123. Richner et al. showed that young naïve CD4+ T cells
have impaired entry one hour after IV transfer into the lymph nodes and spleens of West Nile
virus infected aged mice when compared to young127. Beckuland et al also found that young T
cells transferred IV into young or aged naive hosts had reduced homing into aged lymph nodes
four hours after transfer compared to young lymph nodes128.

Other studies have shown that the aged splenic environment appears to be inhibitory to CD8+ T
cell responses. Jiang et al. transferred young influenza specific Clone 4 CD8+ T cells into young
or aged hosts that had been intravenously infected with influenza virus, and found reduced
expansion and decreased interferon gamma production in aged versus young spleens129. Li et
al. described that after intravenous Listeria-OVA infection, young OTI CD8+ T cells transferred
into young and aged host had reduced expansion in aged compared to young spleen130. These
studies have begun to elucidate a scenario in which the aged “environment” of secondary
lymphoid organs hinders the development of robust T cell responses. Yet which factors of the
aged spleens and lymph nodes are contributing to reduced recruitment and proliferation are
unclear and will be address in chapters three and four of this thesis, with the focus on stromal cell
biology. Our hypothesis predicts that changes in secondary lymphoid organ stromal cell function
many contribute to impaired T cell immunity found in aged mice to influenza infection. Chapter
three will elucidate how aging impacts splenic stromal cells and chapter four explores how aging
impacts lymph node stromal cells.

9

Age-related alterations of lymph node stromal cells
Lymph nodes are highly organized structures important for the development of adaptive and
innate immune responses. In lymph nodes, B cells are segregated to peripheral follicles and T
cells remain in the central T cell zone, also known as paracortex. The medullary sinus is a site
where activated T cells exit the lymph node through lymphatic vessels (Fig. 1A). The majority of
secondary lymphoid organ stromal cell research has focused upon the lymph node stromal cells.
Recent reviews by Fletcher et al.131 and Change et al.

132

describe in detail the biology of the

various lymph node stromal cell niches. Simplistically, lymph node stroma can be divided into four
subsets; lymphatic endothelial cells (LECs), blood endothelial cells (BECs), fibroblastic reticular
cells (FRCs) and cells negative for the markers of these subsets, called double-negative cells
(DNCs)131 (Fig. 1B).
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Figure 1. Lymph node architecture. (a) The main architectural components of a lymph node
are B cell follicles (dashed white line), T cell zone and lymphatic rich medullary sinus. Stroma are
show in green with ER-TR7 staining. The T cell zone contains a net-like fibroblastic reticular cell
(FRC) network magnified in (b). (b) Image of the stromal cell subsets in the lymph node T cell
zone. The FRC network is shown in green as podoplanin (PDPN)+. Lymphatic endothelial cells
(LEC) shown in blue with Lyve-1. Blood endothelial cells (BECs) are shown in red using CD31.
High endothelial venules (HEVs), a subset of BECs, are the cuboidal shaped CD31+ areas, one
of which is denoted by an arrow. Image was acquired using confocal microscopy. (a) scale
bar = 100 μm, (b) scale bar = 70 μm. Images are of mediastinal lymph nodes from C57BL/6 mice.

A technical aside of studying stromal cells, is that they are incredibly difficult to digest out of
secondary lymphoid organs. We have found that a modified version of Fletcher et al.’s digestion
protocol gave the highest viability and yield of all stromal cell subsets from both lymph node and
spleen133. If the digestion is performed improperly, there will be high rates of cell death. It has
been reported that hematopoietic cells in the process of dying can down regulate CD45 and fall
into the stromal cell gate for the DNC population133. Normally DNCs range from 5-10% of the
stromal cell population in lymph nodes133. When the frequency of the DNC population is high in
lymph nodes, this is indicative of poor digestion technique. Three recent studies have attempted
to quantify the number of stromal cells in aged lymph nodes using digestion protocols and flow

11

cytometry, but appear to be caveated by questionable digestions128,134,135. In all of these studies
greater than 50% of the lymph node stromal cells are DNCs, bringing into question the validity of
their quantification. Double-negative cells are a poorly defined subset of lymph node stromal cells,
and they are believed to be contractile FRC-like pericytes136. As little is known about these cells,
it is not surprising that it is unknown how aging changes their function. A recent publication by
Davies et al. claimed that naïve aged cervical lymph nodes had fewer total stromal cells than
young lymph nodes, due to decreases in the numbers of DNCs135. Turner et al. found similar
decreases in the number of DNCs in pooled cervical, axillary, brachial and inguinal naïve lymph
nodes from aged compared to young mice134. The digestions in both of these studies were highly
questionable and need to be repeated before we can understand how aging impacts DNC
numbers in lymph nodes.

Lymphatic endothelial cells are a stromal cell subset that line the lymphatic vesseles137. Lymphatic
vessels are conduits important for maintenance of fluid homeostasis which transport lymph,
soluble antigens and immune cells from tissues to draining lymph nodes138. Aged lymphatic
collectors have increased leakiness and a decreased ability to support active lymph flow139–141,
which results in decreased capacity to transport bacteria141. Functional attrition of aged lymphatics
is due in part to increased oxidative stress and protein carbonylation141. Defects in cellular and
antigenic transport caused by age-related changes in lymphatic collectors may be a contributing
factor behind the delayed initiation to immune responses found in elderly people. How aging
impacts lymph node lymphatic endothelial cells at homeostasis is unclear, although Turner et al.
and Davies et al. found similar number of LECs in young and aged naïve lymph nodes134,135. How
LECs respond in aged mice after immune challenge remains to be determined, and is a focus of
chapter four of this thesis.
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Blood endothelial cells in the lymph node can be separated into capillaries and cuboidal-shaped
high endothelial venules (HEVs)137. BECs facilitate entry of naive T and B cells into the lymph
node137, through a well described multi-step process, called trans endothelial migration. How
aging impacts HEVs or capillaries in the lymph node is still unclear. Richner et al. showed that
aged naive CD4+ T cells transferred into young mice infected with WNV have delayed entry into
the lymph node, and it was observed that aged CD4+ T cells have altered migration through HEVs
compared to young T cells, suggesting T cell intrinsic defects127. However, this study did not
directly examine the changes occurring in aged HEVs, which may contribute to the delayed entry
of young cells into aged lymph nodes. Turner et al. digested pooled cervical, axillary, inguinal and
brachial lymph nodes and found lower frequencies of BECs, but similar number in aged compared
to young lymph nodes at homeostasis134. This study also stated that the localization of BECs in
aged inguinal lymph nodes was more diffuse than young inguinal lymph nodes, but did not
quantity this observation134. A study by Becklund et al. claimed from imaging data of frozen
sections that young and aged lymph nodes have similar numbers of HEVs based on CD31
staining, but also did not quantify their images to support this statement 128. Although when
visualized in frozen section HEVs appear to be plump, cuboidal circles, their true structure is
vastly more complex. In lymph nodes the vasculature forms a tree, with HEVs localizing to specific
branch points142. Either two photon microscopy or tissue clearing must be used to completely
visualize the complexity of the HEV network in lymph nodes. Aging of the vascular system is a
well-studied phenomenon characterized by mechanical and structural changes to the vascular
including arteriolar stiffening 143. It is likely that lymph node blood vessels would experience agerelated changes which could result in delayed immune responses found with increasing age.

Fibroblastic reticular cells are a diverse subset of stromal cells in the lymph node. Follicular
dendritic cells (FDC) are one type of FRC. The impact of aging on FDCs is discussed separately
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below. The most thoroughly studied variety of FRCs are those of the lymph node T cell zone. T
cell zone FRCs maintain the architectural organization of the T cell zone and B cell follicles144.
FRC-produced chemokines CCL19 and CCL21 interact with their receptor, CCR7, on T cells and
dendritic cells controlling the localization of these immune cells to the T cell zone of the lymph
node145. One recent study showed that at steady state, CCL21 concentration was similar in young
and aged popliteal lymph nodes, but after infection with West Nile virus aged lymph nodes had
lower CCL21 concentrations when compared to young lymph nodes127. It is important to note that
this study did not normalize the CCL21 levels to total protein or lymph node weigh, putting into
question their results. Disruption of B cell follicles in aged lymph nodes127,146,147 may suggest
alterations in T cell zone FRCs, but this has not been studied thoroughly. It is unclear whether
there are fewer T cell zone FRCs in the aged lymph node or if the aged FRCs are functionally
impaired. Becklund et at. claimed that there are fewer FRCs in aged compared to young lymph
nodes at homeostasis but did not perform statistics to validate this claim128. Turner et al. and
Davies et al. found that the number of FRCs in aged compared to young naive lymph nodes were
not significantly different135,147.

FRCs proliferate and increase in number after antigenic challenge through a poorly understood
mechanism. This aids in the expansion of the lymph node during immune responses148,149. It
remains to be determined how aging impacts FRC expansion after immune challenge, which is
also addressed in chapter 4 of this thesis. Functional changes in FRCs with age may have a major
impact on the initiation and control of adaptive immune responses in aged individuals. Decreased
CCL21 concentrations may reduce the recruitment and localization of activated dendritic cells and
naive T cells into draining lymph nodes, which could dramatically diminish the magnitude of the
immune response. FRCs are also a major source of IL-7 and CCL19, both of which are important
for survival of naive T cells150,151. Aging reduces the number of naive T cells dramatically, due in
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part to thymic involution, and results in changes to T cell homeostasis152. FRCs may contribute to
T cell homeostatic difficulties if IL-7 and CCL19 production is altered. FRCs also have the ability
to directly inhibit T cell proliferation via production of nitric oxide (NO) when in contact with
activated T cells, IFN-γ and TNFα. The FRC produced NO inhibits T cell proliferation along with
PD-L1 which is upregulated on FRCs153,154. It is possible that aged FRCs have increased inhibitory
capacity and may contribute to impaired T cell immunity, by blocking T cell proliferation in aged
lymph nodes. This hypothesis is address in chapter 4 of this thesis.

A study by Denton et al. demonstrated that FRCs are required for the development of immune
responses to influenza infection. This study used a mouse model in which lymph node FRCs
could be conditionally depleted. When FRCs were depleted before mice were infected with
influenza, this reduced influenza specific PA CD8+ T cell, TFH, GC B cells, and plasma cell
responses. This demonstrated the importance of FRCs in the initiation of the immune response
to influenza. Interestingly if FRCs were deleted six days after the mice were infected with
influenza, there was no change in adaptive immune response formed155. This study provided
evidence that FRCs are required for the initiation of the immune response to influenza, but may
be dispensable after the response has been initiated. How aging impacts lymph node FRCs at
homeostasis and after influenza infection is a major focus of chapter 4 of this thesis.

Age-related alterations of splenic stromal cells
The spleen is a secondary lymphoid organ located in the upper right quadrant of the abdomen
that filters blood, and is a critical component in the defense against blood-borne pathogens such
as encapsulated bacteria156,157. The spleen is compartmentalized into red and white pulp, as
shown in Fig. 2. The white pulp consists of B cell follicles which surround a T cell periarteriolar
sheath. The marginal zone surrounds the B cell follicle. This is where the central arteriole empties
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and immune cells enter the spleen156. Bridging channels are FRC-lined conduits that allow for
entry of immune cells into the splenic T cell zone from the marginal sinus158. A frequently
overlooked component of immune system efficacy is locality159. Immune responses are
dependent upon the interaction of rare cells with one another, and the intricate organization of
secondary lymphoid organs is designed to increase the probability of these interactions
occurring159. With age, there is considerable attrition of splenic white pulp organization. The
splenic marginal zone (B cells160 and macrophages125,161) and follicular dendritic cells162 show
significant disruption with age, and there is also a merging of the B cell follicles and the T cell
areas125,160,163. Stromal cells are a non-haematopoietic component of secondary lymphoid tissues.
In the spleen, the markers podoplanin (PDPN) and CD31 can be used to identify three stromal
subsets: fibroblastic reticular cells (PDPN+CD31–), blood endothelial cells (CD31+PDPN–) and
double-negative cells (PDPN–CD31–), which are mainly red pulp fibroblasts164,165. Unlike the
lymph node, spleens do not contain lymphatic endothelial cells, due to the absence of lymphatic
vessels.

Figure 2. Splenic architecture. The T cell zone of the splenic white pulp is supported by
podoplanin (magenta)-positive fibroblastic reticular cells (FRCs). B cell follicles surround the T
cell zone and are devoid of FRCs, but contain follicular dendritic cells. The red pulp consists of
ER-TR7+ red pulp fibroblasts (green). Bridging channels, lined with FRCs, connect the T cell zone
of the white pulp to the marginal zone and red pulp of the spleen. Image was acquired using
confocal microscopy. Scale bar = 100 μm. Imaged is a C57BL/6 mouse spleen.
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Splenic FRCs (gp38+CD31–ERTR7+) play a variety of roles in the immune response, including
providing a conduit for lymphocytes, dendritic cells158,166 and antigen167 trafficking, production of
homeostatic chemokines important for T and dendritic cell localization to the T cell area (CCL19,
CCL21)145, production of IL-7168, maintenance of the B cell homeostasis and follicular
organization145. A recent report by Aw et al. used microscopy to examine how aging altered
splenic FRC morphology125. In this study, aged mice had an increased area of splenic FRCs which
correlated with the merging of the T cell zones and B cell follicles125. Splenic FRC production of
homeostatic chemokines CCL19 and CCL21 have been shown to decrease in aged mice after
antigenic challenge, which contributes to improper migration of T cells into the T cell zone163. Yet
it remains to be determined if the concentrations of homeostatic chemokine are different at
homeostasis in young and aged mice differ. One report suggests that aged splenic stroma in
vitro have increased production of IL-6, but this study used a relatively crude stromal cell isolation
technique and needs to be repeated169. Studies of human spleens have noted increased collagen
composition in spleens of elderly people170 and attrition of elastic fibres in splenic capsules171.
Further studies are required to determine how aging alters red pulp fibroblasts, and splenic
arteries. Senescence may also have a profound impact upon age-related splenic stromal cell
dysfunction, but this has yet to be determined. Wang et al. quantified senescent cells in the
spleens of aged mice using γH2Ax staining and found that senescence increases with age172.
Further analysis of other senescence markers and careful identification of which splenic cells are
senescent needs to be performed. We are just beginning to understand how aging impacts splenic
stromal cells.

Age-related changes in follicular dendritic cells
Follicular dendritic cells (FDCs) are a subset of FRCs that defines the structure of B cell follicles
in secondary lymphoid organs173. Functionally, FDCs facilitate B cell-mediated responses by

17

maintaining the germinal center and facilitating the production of high-affinity antibodies174. Aging
is associated with a decline in antibody-mediated responses which can, in part, be attributed to B
cell intrinsic defects175 and functional attrition of T follicular helper cell responses94,127,163. Agerelated changes in FDC function may also contribute to the decline of humoral response. One
way that FDCs maintain the organization of the B cell follicle is through production of the
chemokine CXCL13176. Conflicting reports exist about how aging changes CXCL13 production.
Splenic production of CXCL13 in aged BALB/c mice was shown to be increased compared to
young mice at steady state126, whereas 18 hours after antigenic challenge it was determined that
CXCL13 localization in the spleen was diffuse and spread into the T cell areas of aged C57BL/6
mice123. Quantification of CXCL13 in young and aged lymph nodes at steady state showed no
significant difference, but after infection with West Nile virus aged mice had lower CXCL13
levels127. Aged FDCs also have defects in their ability to trap and present immune complexes to
B cells177. Decreased expression of FCγRII, CD21L and FDC-M2 on FDCs after antigenic
challenge may contribute to these defects177–179. Defects in aged FDCs may be a major contributor
to age-related defects in the humoral response.

Goals of thesis
The primary goal of this dissertation is to expand our understanding of how aging impacts various
components of the immune response to influenza infection, with focus on stromal cell biology.
Our hypothesis predicts that changes in secondary lymphoid organ stromal cells are an underlying
and overlooked factor contributing to impaired adaptive immunity to influenza infection in aged
mice.

In chapter two “Age-related impairment of humoral response to influenza is associated with
changes in antigen specific T follicular helper cell responses” we elucidate how aging impacts
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several components of the adaptive immune response to influenza infection. We determine how
TFH and TFR development and function change with age and how these changes may alter humoral
immunity to influenza infection. We also assess the contribution of the aged splenic environment
in the promotion of impaired immune response to influenza infection.

In chapter three “Attrition of fibroblastic reticular cell number and function in aged spleens” we
directly characterize how aging impacts splenic fibroblastic reticular cell numbers, morphology
and function.

In chapter four “Assessment of lymph node stromal cells as an underlying factor in age related
immune impairment to influenza infection” we characterize how aging impacts lymph node stromal
cells at homeostasis and after infection and address our hypothesis that changes in lymph node
stromal cells may be an underling factor contributing to decreased adaptive immunity with age.
We also assess the contribution of fibroblastic reticular cells to the impaired response of young
influenza specific CD8+ T cells transferred into aged versus young mice.

This body of work progresses the field of aging immunology by expanding our understanding of
how aging alters T follicular helper cells, T follicular regulatory cell, splenic stromal cells and lymph
node stromal cells at homeostasis and in response to influenza infection. These studies are of
vital importance for the field of aging immunology because they provide new insight into targets
to modulate to enhance the immune response to influenza infection in hope of protecting the
elderly from the harmful effects of influenza virus.
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CHAPTER 2
Age-related impairment of humoral response to influenza is associated
with changes in antigen specific T follicular helper cell responses
ABSTRACT
T follicular helper (T FH) cell responses are essential for generation of protective humoral
immunity during influenza infection. Aging has a profound impact on CD4 + T cell function and
humoral immunity, yet the impact of aging on antigen specific T FH responses remains unclear.
Influenza specific T FH cells are generated in similar numbers in young and aged animals during
infection, but T FH cells from aged mice exhibit significant differences, including reduced
expression of ICOS and elevated production of IL-10 and IFNγ, which potentially impairs
interaction with cognate B cells. Also, more influenza specific T cells in aged mice have a
regulatory phenotype, which could contribute to the impaired T FH function. Adoptive transfer
studies with young T cells demonstrated that TGF-β1 in the aged environment can drive
increased regulatory T cell accumulation. Aging and the aged environment thus impact antigen
specific TFH cell function and formation, which contribute to reduced protective humoral
responses.

INTRODUCTION
Aging is associated with a dramatic decline in immunity including production of high affinity
neutralizing antibodies1, which leads to increased susceptibility to clinically relevant pathogens
such as influenza. High affinity antibodies are generated by B cells selected in germinal centers
(GC) and GC formation is dependent upon the proper function of T follicular helper (T FH) cells2-5.
Following initial activation, naïve CD4+ T cells progress through several well defined steps to
become functional TFH cells in GCs

6,7

. First, pre-TFH cells up-regulate the B cell follicle homing

chemokine receptor CXCR5 and the transcriptional repressor B cell lymphoma 6 (Bcl6). These
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cells also produce IL-4 and IL-21, key cytokines of B cell activation. This first stage is the result
of T-dendritic cell (DC) interactions and is independent of B cells8. The activated T cells then
progress toward a fully differentiated TFH cell state characterized by the expression of numerous
markers including the inhibitory receptor programmed death (PD)-1, the co-stimulatory molecules
ICOS and OX40, along with the adaptor protein signaling lymphocytic activation molecule
(SLAM)-associated protein (SAP) 9. These molecules facilitate efficient T-B interactions, which
are essential for GC formation. Deficiencies in ICOS

8,10

or SAP

11,12

result in reduced TFH cell

generation and/or reduced GC formation. These interactions with B cells induce the further
differentiation of TFH cells into GC TFH cells, which are identifiable through the sustained
expression of GL7 Akiba, et al.

10,13-15

. Importantly, how aging impacts the stages of TFH cell

generation and differentiation is yet to be determined.

The presence of functional defects in aged CD4+ T cells is now well-established16.

We

demonstrated that aged CD4+ T cells exhibit impaired upregulation of CD15417, suggesting that
reduced B cell activation and humoral responses observed in aged mice could result from
improper T-B interactions. Differentiation of young CD4+ T cells into TFH effectors cells was also
significantly reduced when these cells were transferred into aged hosts18, suggesting that the
aged environment is unable to sustain TFH cell differentiation. These observations were made in
adoptive transfer models using T cell receptor (TCR) transgenic CD4+ T cells. Whether
endogenous antigen-specific aged CD4+ T cells have the ability to acquire a TFH cell phenotype
and/or whether endogenous aged TFH cells have functional defects during infection remains
unclear. A recent study using an OVA immunization model showed that aged mice have more TFH
than young mice but aged TFH were less functional using in vitro assays19. This study did not track
antigen specific responses in vivo, and did not thoroughly define the TFH maturation status.
Moreover, the capacity of aged mice to mount an antigen-specific CD4+ T cell response equivalent
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to that of young mice and whether it correlates with an antigen-specific B cell response remains
to be investigated. Indeed, these are important points and only when they are fully addressed can
we begin to understand the age-related defects in humoral immunity and, more importantly, how
they can be overcome.

Here, we have employed reagents that allow us to follow the responses of endogenous influenza
nucleoprotein (NP)-specific CD4+ T and B cells in young and aged mice. Studying endogenous
antigen specific responses to infection is critical to understanding the full scope of immunological
defects that occur with age. This has allowed us to determine specific defects in responding TFH
cells in aged mice and their impact on humoral responses.

MATERIALS AND METHODS
Mice.
Young (2-4 months) and aged (18-24 months) C57Bl/6 mice were bred and housed at the Trudeau
Institute or University of Connecticut Health Center animal facilities. Alternatively, aged C57BL/6
were obtained from the National Institute of Aging (NIA) aging colony bred and housed at Charles
River Laboratories. Young mice were also obtained from Jackson Laboratories. All mice were
kept in sterilized, individually ventilated, HEPA-filtered cages under specific pathogen-free
conditions. The mice were anesthetized with isoflurane and infected intranasally with 600 PFU of
the mouse-adapted influenza A H1N1 strain Puerto Rico/34/8 (PR8). The mice were sacrificed by
CO2 asphyxiation. Age-matched non-infected mice were used as controls. The Trudeau Institute
or University of Connecticut Health Center Animal Care and Use Committees approved all
experimental procedures using animals and all procedures were carried out in accordance with
their guidelines.
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Determination of antibody titers.
Young and aged mice and were anesthetized with isoflurane and blood was harvested by cardiac
puncture on days 0, 7, 14 and 21 post infection. The blood was allowed to coagulate for 2 hours
at room temperature, centrifuged (×10,000 rpm) 10 min at room temperature, and the serum was
collected and kept at -20ºC until analysis was performed. PR8-specific IgG was determined by
ELISA using HRP-labeled anti-isotype antibodies (Southern Biotech Inc.). Antibody titers were
determined by the last serum dilution with an optical density above background. Neutralizing
antibody titers were determined using an in vitro neutralization assay. In brief, serum dilutions
were incubated with 400 PFU of PR8 for one hour at 37ºC. The mixtures were added on MadinDarby Canine Kidney cell monolayers and centrifuged (×3,000 rpm) 70 min at room temperature.
The cells were next washed and incubated 20-24 hours at 33ºC in Zero-Serum Refeed MediumPSGA (Diagnostic Hybrids) containing 4 µg/ml trypsin (Sigma). The virus was next detected using
a biotin-labeled anti-influenza-A antibody (Millipore). The neutralizing antibody titers were
determined as the last serum dilution with fewer viral plaques than the normal mouse serum
control.

Flow cytometry.
To identify the NP-specific CD4+ T cells, single cell suspensions of splenocytes were first stained
for one hour at room temperature with MHC class II NP Tetramer (PE/APC, Trudeau Institute
Molecular Biology Core Facility). Further phenotyping was performed by staining with directly
fluorochome conjugated antibodies (Table 1). For intracellular transcription factor detection, cells
were fixed and permeabilized using the Foxp3/Transcription Factor Staining Buffer Set
(eBioscience) according to the manufacturer’s instructions. NP-specific GC B cells were detected
by staining with PE labeled B cell tetramer (Trudeau Institute Molecular Biology Core44) for 30 min
on ice. For intra-cellular cytokine staining, samples were enriched for CD4 cells by MACS® using
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the CD4 enrichment kit II (Miltenyi Biotech) according to the manufacturer’s instruction. The cells
were then resuspended at 5-10×106 cells/ml in RPMI (Cellgro) containing 0.18 µM βmercaptoethanol, 4 mM glutamine, antibiotic-antimycotic solution (Cellgro), 10 mM HEPES, 10%
fetal bovine serum and 4 µl/6ml GolgiStop™ (BD). The cell suspensions were stimulated for 5
hours with 1 μg/ml phorbol 12-myristate 13-acetate and 1 µg/ml ionomycin at 37°C. The cells
were

then

washed,

fixed,

and

permeabilized

using

the

BD

Cytofix/Cytoperm™

Fixation/Permeabilization Solution Kit (BD) according to the manufacturer’s instructions. Control
samples containing the different “fluorescence minus one” antibody cocktails were used to
determine the appropriate gating strategy for each cytokine. All flow cytometry samples were
analyzed on a Canto II flow cytometer or on a LSR II flow cytometer using the FACSDiva software
(BD). Data analyses were then performed using the FlowJo software (Tree Star).
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Table 1. Antibodies used for phenotyping T cells, B cells and cytokine production by
flow cytometry.
Antibody
Fluorochrome
Clone
Manufacturer
CD4
APC-eFluor®780
RM4-5
eBioscience
eFluor®450
GL7
FITC
GL7
BD
CXCR5
PE-DazzleTM594
L138D7
BioLegend
BV421
PD-1
PE-Cy7
RMP1-30
BioLegend
CD44
BV510
IM7
BioLegend
CD45
AF700
Dan11mag
BioLegend
CD45.1
BV510
A20
BioLegend
BV421
ICOS
AF488
C398.4A
BioLegend
Ly108
PE
13G3-19D
eBioscience
OX40
PE
OX-86
eBioscience
CD150
PE
Q38-480
BD
CD19
BV650
6D5
BioLegend
PE-Cy7
Bcl6
PerCPBCL-DWN
eBioscience
eFluor®710
Foxp3
eFluor®450
FJK-16s
eBioscience
Peanut lectin agglutinin
FITC
Sigma
CD38
Pacific Blue
90
BioLegend
IFN-γ
FITC
XMG1.2
BD
IL-4
PerCPCy5.5
11B11
BD
IL-2
APC-Cy7
JES6-5H4
BD
IL-10
V450
JES5-16E3 BD
IL-21R Fc chimera
Unconjugated
R&D Systems
(IL-21 Primary)
Goat anti-human IgG Fcγ Frag
PE
Jackson
Specific
ImmunoResearch
(IL-21 Secondary)
Propidium iodide
Sigma
(Live/Dead Indicator)
Carboxylic Acid, Succinimidyl Ester
AlexaFluor®350
Life Technologies
(Live/Dead Indicator)
CD16/CD32
Unconjugated
93
eBioscience
(FC Block)

Immunofluoresence.
Spleens were fixed overnight in medium containing 0.05 M phosphate buffer, 0.1 M l-lysine, pH
7.4, 2 mg/ml NaIO4, and 10 mg/ml paraformaldehyde and were dehydrated with 30% sucrose in
phosphate buffer. Tissues were frozen in Tissue-Tek O.C.T. compound (Sakura Finetek) and
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sectioned using a CM1850 cryostat (Leica). 20-μm frozen sections were permeabilized with 1%
Triton X-100 (Sigma) for ten minutes at room temperature, blocked for 30 minutes with
Background Buster (Innovex Biosciences), stained over night at 4oC in a humidified chamber with
an antibody cocktail (Table 2), then mounted with Immu-Mount (Thermo Sceintific).
Immunofluorescence confocal microscopy was performed with the Zeiss 780 laser scanning
microscope (Carl Zeiss; air objective 20× Plan-Apochromat with NA 0.5) using multichannel frame
scans. The ZEN 2012 software (Carl Zeiss) was used for image acquisition. For half spleen
images, the ZEN 2012 tile scan function was used to stitch individual 20x images together.
Quantification of GC area, GC TFH cells and image processing was performed using Imaris 8.1
software (BITPLANE).
Table 2. Antibodies used for confocal microscopy of TFH.
Antibody
B220
GL7
CD4
Bcl6

Fluorochrome
BV510
AF488
BV421
AF647

Clone
RA36B2
GL7
GK1.5
K112-91

Manufacturer
BioLegend
BioLegend
BD
BD

Adoptive transfer.
The splenocytes were prepared from young non-infected CD45.1+ C57/Bl6 mice (Jackson
Laboratories) and enriched for CD4+ cells by MACS® enrichment kit II (Miltenyi Biotech)
according to the manufacturer’s instruction. Purity of this population was confirmed by flow
cytometry (>85%). The isolated young CD45.1+CD4+ T cells were tail vein injected into young or
aged CD45.2+ C57BL/6 hosts at 3.6x107 cells/200μl/ mouse. One day later the mice were infected
with 600 PFU PR8 influenza and subsequently sacrificed 14 days later for flow cytometric
analysis.

44

Active TGF-β 1 ELISA.
Prior to flow analysis, the spleens from young and aged mice that received adoptive transfer of
young CD45.1+CD4+ T cells, where crushed through 100μM wire mesh with 400μL of PBS. The
suspension was then centrifuged (x300 rpm) for 2 minutes and supernatant was collected and
stored at -80oC until analysis was performed. TGF-β1 was measured in the spleen supernatants
using the LEGEND MAXTM Free Active TGF-β1 ELISA kit (BioLegend). Samples were run in
duplicate according to manufactures instructions. Spleen weights did not differ significantly in
young and aged mice (data not shown).

In vitro generation of regulatory T cells.
A sterile single cell suspension was prepared from spleens and lymph nodes pooled from four
young mice. Erythrocytes were lysed using ACK lysis buffer (Gibco by Life Technologies). CD4+
T cells were isolated by negative selection using Miltenyi’s CD4 cell isolation kit according to
manufactures instructions. The CD4+ population was then stained with PE conjugated anti-CD25
(BD). After washing, the cells were then incubated with anti-PE microbeads (Miltenyi). CD25+
cells were removed by positive selection using the LS column (Miltenyi). Purity of the CD25-CD4+
T cells was confirmed by flow cytometry. The purified cells were suspended at 2x106 cells/ml in
X-Vivo15 serum free medium (Sartorius Stedim Biotech) and cultured in 24 well plates with
Dynabeads® Mouse T-Activator CD3/CD28 (Life Technologies) at a bead to cell ratio of 1:1. TGFβ1(R&D Research Systems) was either added at 5000pg/ml (recommended concentration for
generation of regulatory T cells (Fantini, et al 35) 100 pg/ml (concentration found in aged spleens),
or 0 pg/ml (negative control). All conditions were plated in triplicate and cultured for 5 days at
37oC 5%CO2.
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Statistical analyses.
All experiments were performed at least twice, and each group contained 3-7 animals. Statistical
significance was determined by Student’s t test, Oneway or Two way ANOVA, Repeated
Measures ANOVA, or Pearson’s correlation as specified in the figure legends. Statistical analyses
were performed with Prism 5 or Prism 6 software (GraphPad Software inc.) or SPSS Software
(IBM). Differences were considered significant at p<0.05.

RESULTS
Impaired humoral response in aged mice following influenza infection
One hallmark of aging is the inability to mount a strong humoral response. Aged mice infected
with a sublethal dose of influenza A H1N1 PR8 generated significantly lower titers of influenzaspecific IgG (Fig. 3A) and neutralizing antibodies (Fig. 3B) compared to young. Generation of
high-affinity antibodies is dependent upon formation of GCs, which can be impacted by agerelated functional declines20. Thus, we sought to investigate the contribution of GCs to diminished
formation of influenza-specific antibody titers in aged mice in this model.

GC B cells were identified as CD19+ PNAhi CD38lo cells (boxes in Fig. 3C). The kinetics of total
(Fig. 3C and D) and NP-specific (Fig. 3I and J) GC B cell generation were similar for both young
and aged mice, with the proportion and number peaking at 14 days post-infection (dpi). However,
the amplitude of the response was significantly lower in aged compared to young mice. At 14 dpi,
approximately 1% of total B cells acquired a GC B cell phenotype in aged mice compared to a
proportion of over 7% in young mice (Fig. 3C). This translated to a significantly lower number of
total GC B cells produced in the spleens of aged compared to young mice (Fig. 3D).
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Upon examination of the splenic GCs using confocal microscopy, there were clear morphological
differences in young and aged mice (Fig. 3E). At the peak of the GC response (14 dpi), aged
mice exhibited significantly fewer (Fig. 3F) and smaller GCs (Fig. 3G) compared to young mice.
Importantly, there was a strong correlation between the number of splenic GCs and weight
recovery at 14 dpi (Fig. 3H). Young and aged mice that generated more splenic germinal centers
had increased weight recovery after influenza infection (Fig. 3H), indicating that rapid recovery
from influenza infection is correlated with robust GC formation. The percentage of GC B cells
that were specific for NP was slightly, but not significantly, lower in aged (22.7 ± 7.2%) compared
to young mice (37.7 ± 3.9%, p=0.104) (Fig. 3I) at 14 dpi, but the total number of NP+ GC B cells
in aged mice was approximately ten-fold lower than in young mice (Fig. 3J).

Despite age related declines in B cell function21, young polyclonal CD4+ T cells transferred into
aged hosts can overcome the defects in GC B cell numbers normally found in aged mice at 14dpi.
When aged mice were supplemented with young CD4+ T cells prior to infection (aged

+

CD4

group), the number of total (Fig. 3K) and NP specific (Fig. 3L) GC B cells reaches that of the
endogenous response of young mice (young group) at 14 dpi, emphasizing the importance of
efficient CD4+ T cell help in the development of a robust B cell response. These results are in
concordance with our previous finding that young TCR transgenic CD4+ T cells can overcome B
cell defects in aged CD4 KO mice 17. Thus, the remainder of this study was aimed at determining
how age-related defects in the CD4+ T cell response contribute to the impaired humoral response
in aged mice.
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Figure 3. Reduced antibody production and GC development during influenza infection in
aged mice. (A) Influenza-specific IgG titers, and (B) influenza-neutralizing antibody titers in young
and aged mice infected with 600 PFU of PR8 at 0, 7, 14 and 21 dpi. Data are the mean ± SEM of
4-5 mice/group from a representative experiment of 4 independent experiments. (C) Kinetics of
CD38/PNA expression following influenza infection after gating on live CD19+ lymphocytes. The
gates delineate the GC B cell population (PNAhi CD38lo) with numbers adjacent representing
frequency of GC B cells. The data are 5 mice/group from a representative experiment of 3
performed independently. (D) Total number of splenic GC B cells determined using the gating
strategy shown in (C). Data are the mean ± SEM of 8-13 mice/group from three independent
experiments. (E) Representative half spleen images from young and aged mice 14 dpi, GL7
(green) B220 (magenta) with scale bar at 500μm. GC numbers per half spleen (F) and GC area
(G) quantified by confocal microscopy. (H) Correlation of splenic GC number and weight recovery
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at 14 dpi. Data are the mean ± SEM from 3 combined experiments with 3-4 mice per group. (I)
Frequency of NP-specific GC B cells (gated as in (C). Histograms show data of 4-5 mice/group
from one representative experiment of two performed independently. (J) Total splenic NP-specific
GC B cells determined using the combined gating strategies shown in (C) and (I). Data are the
mean ± SEM of 8-13 mice/group from three independent experiments. Number of total (K) or NPspecific (L) GC B cells at 14 dpi in young or aged mice that received/did not receive 3.6x107 young
CD45.1+CD4+ T cells one day prior to infection with PR8, gated on CD45.1- GC B cells as in (C
and I). Data are the mean ± SEM of 4-7 mice per group from a representative experiment of 2
performed independently. Statistical significance was determined by (A,B,D,J) two-way ANOVA
(Bonferronni’s post tests), (F), (G), Student’s t test, (H) Pearson's correlation and (K,L) one-way
ANOVA (Tukey HSD post tests). *, p<0.05,**, p<0.01; ***, p<0.001; ****, p<0.0001.

Aged influenza specific CD4+ T cells differentiate into pre-TFH cells
To determine how the antigen specific CD4+ T cell response is affected by aging, we used a MHC
Class II influenza nucleoprotein (NP)-specific tetramer to track cells in young and aged mice
following infection. Figure 4A shows a representative gating strategy for phenotyping young (top
row) and aged (bottom row) NP-specific CD4+ T cells 14 dpi. The kinetics and number of NPspecific CD4+ T cells accumulating in the spleen of young and aged mice following influenza
infection were equivalent (Fig. 4B). Analysis of NP-specific CD4+ T cells showed that most (~70%)
displayed a TFH cell phenotype (CXCR5hi PD-1hi) at 14 dpi (Fig. 4A, red boxes), but also at 7 and
21 dpi (data not shown). The numbers of NP-specific TFH cells were also equivalent in both young
and aged mice at all time-points tested (Fig. 4C). Also of note, a higher percentage of NP Tetneg
CD44lo CD4+ T cells in aged mice express PD-1 compared to young mice (Fig. 4A blue box), a
feature characteristic of aging cells22,23. Total TFH responses did not follow the trend of the antigen
specific response, with aged mice having a higher frequency and number of TFH than young mice
before infection, seven days post infection and twenty one days post infection (Fig. 5). Young
mice responded to influenza infection with an expansion of TFH that peaked at day 14 post
infection (Fig. 5). Aged mice had relatively stable TFH numbers and frequency through the infection
(Fig. 5), demonstrating that total response is not representative of the antigen specific response
occurring in aged mice.
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To confirm the identity of the CXCR5hi PD-1hi NP-specific CD4+ T cells as TFH cells, we assessed
their expression of Bcl6, the central driver of TFH cell differentiation180. Bcl6 expression in both
young and aged NP-specific TFH cells was compared to the CXCR5lo PD-1lo CD4+ population (Fig.
4D). The Bcl6 mean fluorescence intensities (MFI) of young and aged NP-specific TFH cells were
not significantly different (Fig. 4E). To further confirm that both young and aged NP-specific CD4+
T cells were differentiating into TFH cells, we assessed their ability to produce IL-4 and IL-21,
cytokines produced by TFH cells that are important for GC generation. Due to the limitation in the
number of markers that could be used at once for flow cytometry analyses, and since the great
majority of the Ag-specific CD4 T cells displayed TFH characteristics (Fig 4A), we considered that
the splenic Ag-specific CD4 T cells were T or “TFH-committed” cells for the remainder of these
studies. In agreement with the differentiation of CD4+ T cells to a TFH cell phenotype, both young
and aged NP-specific CD4 T cells produced IL-4 (Fig. 4F) and IL-21 (Fig. 4G) in similar
proportions. Thus, our data demonstrate that age does not impair the ability of CD4+ T cells to
differentiate into pre-TFH cells (CXCR5+ Bcl6+ CD4+ T cells)6. Since our previous data using aged
TCR transgenic cells showed that aged CD4+ T cells exhibit defective helper function 17, we
hypothesized that defects in the later stages of TFH cell differentiation may be impaired in aged
NP-specific CD4+ T cells.
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Figure 4. Aged CD4+ T cells differentiate into pre-TFH cells. (A) CXCR5/PD-1 expression of
young (top row) and aged (bottom row) Tet+ CD44hi (red boxes) and Tetneg CD44lo (blue boxes)
cells after gating on live CD4+ T lymphocytes at 14 dpi. Plots show concatenated data of 5
mice/group from one representative experiment of three performed independently. (B) Total
number of splenic NP-specific CD4+ T cells determined by flow cytometry using the gating strategy
shown in (A). Data are the mean ± SEM of 8-13 mice/group pooled from three independent
experiments. (C) Total number of splenic Tet+ CXCR5hi PD-1hi in young and aged mice
determined by flow cytometry using the gating strategy shown in (A). Data are the mean ± SEM
of 8-13 mice/group pooled from three independent experiments. (D) Bcl6 expression by young
and aged NP-specific CXCR5hi PD-1hi CD4+ T cells at 14 dpi. Negative expression (dashed line)
was determined using young CXCR5lo PD-1lo CD4 T cells. The histogram represents
concatenated data of 5 mice/group from one representative experiment of three performed
independently. (E) Bcl6 MFI shown in (D). Frequency of young and aged NP Tet + CD4+ T cells
producing (F) IL-4, and (G) IL-21 following PMA and ionomycin stimulation at 7 dpi. The data
show the mean ± SEM of 5 mice/group from one representative experiment of two performed
independently. Statistical significance was determined by Student’s t test.
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Figure 5. Increased number of T follicular helper cells and T follicular regulatory cells in
aged mice compared to young mice. Young and aged mice were infected with 600 pfu PR8
influenza virus. (A)Representative flow cytometry plots of T follicular helper cells from noninfected, day 7, day 14 and day 21 post infection were gated on alive, CD19-, CD4+ cells that
expressed CXCR5 and PD-1. Total number of T follicular helper cells through the course of
influenza infection (B). (C Left) The frequency of T follicular regulatory cells at 14 days post
infection, gated as in figure A, with the addition of Foxp3. (C Right) Total number of T follicular
regulatory cells in young and aged mice through the course of influenza infection. Data shown
are one representative experiment with mean ± SEM of 5-8 mice/group from 3 independent
experiments.
Statistical significance was determined by two-way ANOVA followed by
Bonferronni’s post tests.*, p<0.05,**, p<0.01.

Aged influenza specific CD4+ T cells have impaired differentiation to a mature TFH cell
phenotype
Following the pre-TFH stage, cells upregulate the expression of surface markers involved in T-B
interactions, and migrate to the T-B cell border where their initial interaction with B cells occurs.
To determine if aged NP-specific T cells express the appropriate cell surface molecules to interact
efficiently with B cells, we evaluated expression of ICOS, Ly108, OX40 and CD150 on young and
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aged NP-specific T cells (Fig. 6). ICOS and Ly108 surface expression on aged NP-specific CD4+
T cells were significantly lower than on young CD4+ T cells. Conversely, the expression of OX40
on aged NP-specific CD4+ T cells was significantly higher. CD150 expression was similar on both
young and aged cells.

These data suggest that aged NP-specific CD4+ T cells may have impaired ability to interact with
B cells due to their failed ability to appropriately up-regulate ICOS and Ly108. Since ICOS and
Ly108 play an important role in T-B interactions and GC formation10,25, lower expression of these
molecules may contribute to the functional defects of aged CD4+ T cells which in turn may
contribute to the reduced humoral responses observed in aged mice.
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Figure 6. Aged CD4+ T cells fail to progress to fully differentiated TFH cells. (Left) Histograms
showing ICOS, Ly108, OX40 and CD150 expression by young and aged NP Tet+ CD4+ T cells at
7 dpi. Negative or baseline expression (dashed line) was determined using the young Tet neg
CD44lo CD4 T cell population. (Right) MFI of the histograms shown on left. The histograms (Left)
show concatenated data, and the graphs (Right) show the mean ± SEM, of 5 mice/group from
one representative experiment of two performed independently. Statistical significance was
determined by Student’s t test.**, p<0.01 ****, p<0.0001.
The last stage of TFH cell differentiation corresponds to entry into the GC. This is characterized by
the expression of GL7, a marker expressed by TFH-committed CD4+ T cells 13 and associated with
the mature GC TFH cell phenotype14. Considering that the NP+ pre-TFH have altered receptor
expression that may impair their interaction with cognate B cells, we expected that the progression
of the aged NP-specific CD4+ T cells to the final GC T cell phenotype may also be impaired. We
therefore evaluated whether aged TFH cells were progressing normally to the GC TFH cell
phenotype by evaluating GL7 expression on these cells. While 34.5% of the young NP-specific
CD4+ T cells up-regulated GL7 at 7 dpi, only 19.7% of the aged cells were GL7 positive at that
time-point (Fig. 7A). This resulted in a significantly higher number of GC NP-specific CD4+ T cells
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in young compared to aged mice which were maintained at 14 dpi (Fig. 7B). To further explore
the incomplete differentiation of aged antigen specific TFH cells to a GC TFH cell phenotype, we
analyzed the expression of CXCR5, an important molecule for the migration of pre-TFH cells into
the GC3. The aged NP-specific TFH cells exhibited lower expression of CXCR5 compared to their
young counter parts (Fig. 7C), corresponding to a pre-TFH cell phenotype14.

Our data thus far indicate that aged influenza specific CD4+ T cells differentiate normally to a preTFH cell phenotype, but less progress to a mature GC phenotype compared to young mice. To
visualize this immunological reaction in situ we used multi-color confocal microscopy. Due to the
limitations of imaging with MHC class II tetramers, we focused on visualizing the total response
to influenza infection in young and aged spleens. There was increased GC disorganization, noted
by the scattered GL7+ areas (Fig. 7D, left panels). The merged images demonstrate that aged
mice had notable disruption of their splenic white pulp architecture when compared to young,
denoted by the merging of the T and B cell areas (Fig. 7D, right panels). The considerable
disruption of the microarchitecture observed in GCs from aged mice could also contribute to the
reduced production of a protective humoral response. Next we sought to determine if TFH localize
to the germinal center comparably in aged and young mice. TFH cells were identified by colocalization of Bcl6 and CD4 (Fig. 7E, insert from Fig. 7D middle panel). To quantify GC TFH cells,
the cells expressing CD4 and Bcl6 in the GL7+ areas were counted. Aged mice had fewer TFH
cells per GC compared to young mice at 14 dpi (Fig. 7F) in concordance with our antigen specific
TFH flow cytometry data (Fig. 7B). However, since the size of each GC is smaller in area in aged
mice when compared to GC in young mice (Fig. 3G), the number of TFH per 1000 μm2 of GC is
not different between young and aged mice (Fig. 7G). From this data we can conclude that the
decreased number of TFH in the germinal center is a function of the decreased germinal center
size, not density.
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Figure 7. Decreased germinal center TFH cell response to influenza infection in aged mice
(A) GL7 expression on young and aged NP Tet+ CD4+ T cells. Negative expression (dashed line)
was determined using young NP Tetneg CD44lo CD4+ cells. The histograms show concatenated
data of 4-5 mice/group from one representative experiment of 3 performed independently.
Numbers in the upper right corners are the frequency of the young (black) and aged (grey) cells
in the GL7+ gate. (B) Total number of splenic NP Tet+ GL7+ cells determined by flow cytometry
using the gating strategy shown in (A). Data represents the mean ± SEM of 14-18 mice/group
from 3 independent experiments. (C) CXCR5 MFI of NP Tet+ TFH cells from young and aged mice
at 7 and 14 dpi (using gating strategy from Fig. 2A). Data represents the mean ± SEM of 3-7
mice/group from 3 independent experiments. (D) Representative images of spleens from young
(top row) and aged (bottom row) mice 14 dpi stained with GL7 (green) to denote GCs, CD4
(yellow), Bcl6 (red) and B220 (magenta) with scale bars at 80μm. Inserts in the middle panel are
magnified in figure (E). (E) TFH cells were characterized by co-localization of Bcl6 and CD4 (white).
(F) TFH cells per GC were enumerated by counting the TFH cells in the GL7 area using Imaris
software. (G) TFH cells per 1000μm2 GC area were calculated using the GC area (determined by
creating an isosurface of GL7 with Imaris) and the number of T FH cells per GC. Data are mean ±
SEM pooled from three independent experiments with images from 17 mice containing 1-4 GC
per image (D, E, F). Statistical significance was determined by Student’s t test. *, p<0.05; **,
p<0.01, ***, p<0.001.
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Taken together, these data support the hypothesis that the activation and differentiation of the
aged NP-specific CD4+ T cells in response to influenza infection is impaired and results in lower
numbers of GC TFH cells that may contribute to a deficient GC response. We then interrogated
the expression of PD-1 on young and aged CD4 T cells during influenza infection since increased
PD-1 expression on aged TFH was described recently by Sage et al19 , who suggested that
increased PD-1 expression could be responsible for the reduced function of aged TFH. The total
aged CD4 T cell population (Fig. 8 A,B,C) as well as the total aged TFH population (Fig. 8D,E) do
indeed express higher levels of PD-1 when compared to young. Importantly, and in contrast to
the report by Sage et al, there is no difference in PD-1 expression on NP-specific TFH from young
and aged mice at 7 dpi (Fig. 8F) and by 14 dpi, young TFH express higher levels when compared
to aged (Fig. 8G). Thus, in our influenza model, increased expression of PD-1 by aged Ag-specific
TFH cannot account for their reduced function.
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Figure 8. Differential expression of PD-1 on young and aged T follicular helper cells. Young
and aged mice were infected with 600 pfu PR8 influenza virus and the splenic response was
determined at 7 and 14 days post infection. PD-1 MFI of total CD4+ T cells (gated on lymphocytes,
single cells, alive, CD4+) of A) naïve mice, B) 7 days post infection and C) 14 days post infection.
The PD-1 MFI of T follicular helper cells gated as described in Fig 5. was determined in D) 7 days
post infection and E)14 days post infection. The expression of PD-1 on NP Tetramer+ T follicular
helper cells (as gated in Fig. 2) was determined F) 7 days post infection and G)14 days post
infection. Data shown are one representative experiment with mean ± SEM of 3-8 mice/group
from 2 independent experiments. Statistical significance was determined by the Mann-Whitney
Test.*, p<0.05,**, p<0.01.
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NP-specific CD4+ T cells from aged mice have a regulatory-like phenotype
Since the progression of CD4+ T cells into fully differentiated GC TFH cells is impaired in aged
mice, we hypothesized that their B cell helper activity would be affected. In the next series of
experiments, we evaluated the IL-2, IL-10 and IFNγ production by young and aged NP-specific
CD4+ T cells by flow cytometry. Consistent with previous reports26, the proportion of aged NPspecific CD4+ T cells producing IL-2 was significantly lower than that of young cells (Fig. 9A).
Interestingly, a higher frequency of aged cells produced IL-10 (Fig. 9B) and IFNγ (Fig. 9C) than
young cells. The dysregulated cytokine production by aged NP-specific CD4+ T cells could
indicate an inappropriate effector differentiation program that might impact helper activity of these
cells, and therefore, the formation of GCs.
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Figure 9. NP-specific CD4+ T cells produce cytokines indicative of regulatory T cells.
Intracellular cytokine staining of young and aged NP Tet+ CD4+ T cells harvested 7 dpi and
stimulated with PMA/Ionomycin. The graphs show the mean ± SEM of the frequency of NPspecific CD4+ T cells producing: (A) IL-2, (B) IL-10, and (C) IFNγ. The data are from 5 mice/group
of one representative experiment of two performed independently. Statistical significance was
determined by Student’s t test. ***, p<0.001; ****, p<0.0001.
Reduced IL-2 production combined with increased IL-10 production is reminiscent of a regulatory
T cell phenotype and it is reported that the frequency of regulatory T cells increases with aging2730

. Upon examination of total Foxp3+ CD4+ T Cells our data also showed increased frequency

of regulatory T cells in aged mice at all time points test (Fig. 10A,B). Total number of regulatory T
cells was only significantly higher in aged mice at steady state and seven days post influenza
infection (Fig. 10C). To determine if more aged NP-specific CD4+ T cells exhibited regulatory T
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cell properties, we evaluated Foxp3 expression in young and aged influenza infected mice. At 7
dpi, the number of NP-specific CD4+ T cells expressing Foxp3 was not significantly different in
young and aged groups (Fig. 10D). By 14 dpi however, the number of NP-specific CD4+ T cells
expressing Foxp3 was significantly higher in aged compared to young mice (Fig. 10E). Recently,
a subset of regulatory T cells that specifically control GC B cell and GC T FH cell responses, T
follicular regulatory (TFR) cells, was characterized. TFR cells are identified by expression of CD4,
PD-1, CXCR5, Foxp3 and Bcl631-33. At 7 dpi there was no difference in NP-specific TFR cell
formation (Fig. 10F), but at the peak of the GC response (14 dpi) aged mice had increased
numbers of NP-specific TFR cells (Fig. 10G). Total TFR cell number was also increased aged mice
compared to young mice at all time points post infection (Fig. 5). The increase in NP-specific TFR
cells and regulatory T cells may contribute to the poor GC TFH cell and humoral response observed
in aged mice after influenza infection. In order to further understand how aging impacts regulatory
cells, we next explored the contribution of the aged environment to their formation.
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Figure 10. T regulatory and T follicular regulatory cells accumulate in aged mice after
influenza infection (A) Representative histograms of total CD4+ T cells expressing Foxp3 in
young and aged mice. Frequency(B) and number (C) of total CD4+ T cells that express Foxp3 in
spleens from young and aged mice before influenza infection, 7dpi and 14dpi. Number of NPspecific CD4+ T cells expressing Foxp3 in the spleen of young and aged mice at (D) 7 dpi and (E)
14 dpi. Number of NP-specific CD4+ CXCR5hi PD-1hi Bcl6+ Foxp3+ cells in spleens of young and
aged mice at (F) 7 dpi and (G) 14 dpi. Data are the mean ± SEM of 3-10 mice per group from a
representative experiment of 3 performed independently. Statistical significance was determined
by Two way ANOVA with LSD post hoc (B,C) or Student’s t test (D,E,F,G). *, p<0.05, p<0.001.

Impact of the aged environment on regulatory T cells
To assess whether the accumulation of regulatory T cells in aged mice was cell intrinsic or if the
aged environment contributed to their accumulation, we performed an adoptive transfer
experiment. Young and aged mice received young polyclonal CD45.1+ CD4+ T cells one day prior
to influenza infection. We employed a polyclonal model for this experiment since TFR cells are
thymically derived and are not present in TCR transgenic populations such as the OT-II model31.
The phenotype of the young CD4+ transferred T cells was analyzed by flow cytometry 14dpi. A
greater frequency of donor T cells in aged mice expressed Foxp3 when compared to donor cells
in young mice (Fig. 11A). This was complemented by the increased regulatory to effector ratio of
young CD4+ transferred cells in aged hosts (Fig. 11B). Examination of donor CD4+ T cells
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expressing a TFR phenotype (Bcl6+ and Foxp3+) showed no difference in frequency in young or
aged hosts (Fig. 11C). Although the factors that promote TFR cell development are still being
elucidated, TGF-β1 is a known inducer/stabilizer of Foxp3 expression34. There was a significantly
higher level of active TGF-β1 in the spleens of aged mice compared to young mice at 14 dpi (Fig.
11D), which may contribute to accumulation of regulatory T cells in aged hosts. To determine
whether the concentration of active TGF-β1 in the aged spleens was sufficient to promote
regulatory T cell development, we performed an in vitro assay where young CD4+CD25- T cells
were cultured with either a standard concentration (5000 pg/ml) of TGF-β1 to polarize T cells to
regulatory cells35, the concentration of TGF-β1 in aged spleens (100pg/ml) or no TGF-β1. TGFβ1 at 100pg/ml converted CD4+T cells to regulatory T cells at a similar frequency (7%) to the in
vivo transfer experiments (Fig. 11E), suggesting that TGF-β1 in the aged splenic environment can
drive formation of regulatory T cells. These data suggest that there are both CD4+ T cell intrinsic
and extrinsic factors that contribute to the regulatory environment of aged mice, which may
negatively contribute to TFH cell function and, in turn, dampen the humoral response in aged mice
during influenza infection.
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Figure 11. More young CD4+ T cells transferred into aged host express Foxp3 compared to
young hosts Purified young CD45.1+CD4+ polyclonal T cells were transferred via tail vein
injection into young or aged hosts at 3.6x107 cells per mouse. One day post transfer, recipient
mice were infected with 600PFU PR8 influenza and subsequently sacrificed for analysis 14 days
later. (A) Foxp3 expression of CD4+ transferred cells in young or aged hosts. (B) Regulatory to
effector ratio of CD4+ transferred cells in young or aged host, calculated by the percent of
Foxp3+/Foxp3- donor CD4+ cells. (C) CD4+, CXCR5hi, PD-1hi, Bcl6+ transferred cells expressing
Foxp3 in young or aged host. (D) Active TGFβ-1 levels in spleen supernatants from the mice who
received transferred cells described above. Data are the mean ± SEM of 4-7 mice per group from
a representative experiment of 3 performed independently. Statistical significance was
determined by Student’s t test (A,B,C,D). *, p<0.05.***, p<0.001. (E) CD4+CD25- T Cells from
young mice were cultured with 5000 pg/ml (standard concentration for making iTregs 35) , 100
pg/ml (concentration in aged spleens) or 0pg/ml TGF-β1. Combined results from three
independent experiments. Statistical significance was determined using repeated measures
ANOVA with Sidak post hoc test. *p<0.05.
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DISCUSSION
Aging is associated with a decline in immune system function, including reduced humoral
responses. Here we show that low influenza-specific antibody titers found in aged mice following
influenza infection are associated with decreased numbers of total and NP-specific GC B cells
and decreased GC size, number and responses compared to young mice. We have also shown
that defects in total and NP-specific GC B cell numbers can be overcome by the addition of young
CD4+ T cells. This suggests that B cell intrinsic defects are likely insufficient to explain the extent
of the GC impairment and that other factors, such as age-related changed in TFH cells, may
contribute to these defects.

In previous studies, we have shown that aged CD4+ T cells acquire intrinsic defects that impair
their helper functions17,36. These conclusions were drawn following the observation that aged TCR
transgenic CD4+ T cells transferred into young CD4 KO mice support a weaker GC response
when compared to young CD4+ T cells. This age-associated functional defect was correlated with
impaired CD154 expression. Moreover, we have demonstrated that the aged micro-environment
also contributes to reduced helper function of CD4+ T cells using an adoptive transfer model18. In
these experiments, young CD4+ T cells displayed delayed activation and expansion, as well as
reduced differentiation to a TFH cell phenotype, when transferred into aged hosts when compared
to young hosts18. This correlated with the impaired accumulation of the young donor cells in the
T cell areas of the spleen in aged mice, a phenomenon likely related to the reduced expression
of CCL19 and CCL21 in this organ18. These experiments allowed us to determine the contribution
of the age-associated defects intrinsic and extrinsic to the CD4+ T cell compartment in the
impaired GC response observed in aged mice.
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Results presented herein provide evidence that endogenous, aged antigen-specific CD4+ T cells
exhibit a defect in their ability to fully differentiate to a GC T FH cell phenotype in response to
influenza infection. While the same number of NP-specific CD4+ T cells acquired pre-TFH
characteristics (CXCR5+ PD-1+ Bcl6+) in young and aged mice, aged TFH cells express lower
levels of ICOS and Ly108 and fewer expressed GL7, a marker for GC T FH cells. Importantly, this
defect in TFH cell differentiation is associated with impaired generation of NP-specific GC B cells.
GL7 is a molecule readily expressed by activated NP-specific CD4+ T cells and maintenance of
its expression in GC TFH cells depends on the establishment of cognate T-B interactions13. Thus,
we believe that the low frequency of aged NP-specific CD4+ T cells expressing GL7 is indicative
of inadequate T-B cell interactions.

The hypothesis that aging negatively impacts T-B cell interactions is supported by several
observations. First, the reduced number of NP-specific B cells in the spleen of aged mice likely
contributes to the impaired GL7 expression. Second, this could be the result of impaired
recruitment of T cells to B cell follicles. Our current findings are in agreement with our previous
work showing that the architecture of B cell follicles in aged mice spleens was disorganized18.
Moreover, the amount of CCR7 ligands CCL19 and CCL21 were significantly lower 18, while the
CXCR5 ligand CXCL13 was more abundant 37 in aged compared to young mouse spleens. These
signals may contribute to smaller GCs found in aged mice that have fewer T FH cells than their
young counterparts. Because of the imbalance of chemotactic signals and the disorganization of
the splenic white pulp, the ability of aged TFH cells to find and interact with their cognate B cells is
likely compromised in aged mice.

Furthermore, we observed that expression of the co-stimulatory molecule ICOS was significantly
reduced on aged compared to young NP-specific CD4+ T cells. A recent study by Xu and
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colleagues showed that ICOS participates in CD4+ T cell localization within B cell follicles in an
ICOS ligand-independent manner15. A lower expression of ICOS on TFH cells could reduce their
ability to migrate within the follicles and interact with B cells. In concordance with these results,
we also showed that NP-specific TFH cells have lower expression of CXCR5, another important
molecule for homing of TFH cells to B cell follicles3. ICOS has a central role in multiple steps of the
GC reaction, and ICOS deficient CD4+ T cells are unable to differentiate to a TFH cell phenotype10.
The equivalent generation of NP-specific TFH cells in both young and aged mice, albeit with the
lower expression of ICOS by the aged cells, suggests that this level of ICOS expression is
sufficient for initial TFH cell differentiation, but not for full differentiation to a GC TFH cell phenotype.
ICOS signaling also contributes to the GC response by inducing the expression of other costimulatory molecules such as CD40L38-40 and influencing cytokine production by T cells38-40 and
GC B cells41. Ly108 has also been identified as a major regulator of T-B cell interactions25 through
both positive and negative signals42. The reduced expression of both ICOS and Ly108 by the
aged NP-specific CD4+ T cells could therefore have a major impact on the stability of the T-B cell
interactions and the subsequent development of GCs.

Finally, we observed that a greater number of NP-specific CD4+ T cells express the transcription
factor Foxp3 in aged compared to young mice, with fewer aged cells producing IL-2 and more
cells producing IL-10. Increased regulatory T cell frequency and/or number in aged mice have
been reported by multiple groups27-30 and this increase has also been linked to reduced immune
function27,30. Interestingly, the proportion of GL7+ GC TFH cells is increased in mice deficient in
regulatory T cells 43. TFR cells are important suppressors of GC B cell and TFH cell responses that
are derived from thymic regulatory T cells31-33. The increase in Foxp3+ regulatory T cells found
in aged mice could contribute to the increased number of total and antigen specific TFR cells found
in aged mice. Sage et al. in a recent report demonstrated that young and aged T FR cells have
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equal suppressive capacity. Therefore, TFR cell from aged mice could contribute to reduced GC
B cell and GC TFH cell generation after infection. We have also demonstrated that the aged
environment is conducive to regulatory T cell development, in part due to increased levels of
active TGF-β1, a known inducer of Foxp3 expression34. Future studies will address the cellular
source of TGF-β in aged mice.

In conclusion, we show that an appropriate number of NP-specific CD4+ T cells develop to preTFH cell stage in aged mice. However, these cells are unable to fully progress to the GC T FH
phenotype (GL7+ TFH cells)14, and sustain the development of an efficient GC response when
compared to the young NP-specific TFH cells. Thus, we propose that inadequate T-B cell
interactions, as well as increased regulatory T cell number in aged mice contribute to age-related
impairments in humoral responses to influenza infection (Fig. 12).
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Figure 12. Chapter 2 graphical summary.
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CHAPTER 3
Attrition of fibroblastic reticular cell number and function in aged
spleens
ABSTRACT
Aging has a profound impact on multiple facets of the immune system culminating in aberrant
functionality. The architectural disorganization of splenic white pulp is a hallmark of the aging
spleen, yet the factors underlying these structural changes are unclear. Fibroblastic reticular cells
(FRCs) are one stromal cell subset in the spleen important for maintenance of architectural
organization, yet it remains to be determined how aging impacts these cells. In this study, we
sought to determine how aging impacts splenic FRC numbers, morphology and function. Using a
mouse model of aging, we found that aged naïve spleens have fewer FRCs than young spleens.
This reduction in FRC number correlated with reduced CCL19 and CCL21 concentrations in aged
spleens, which may contribute to impaired homing of T cells. CCL21 in both young and aged
spleens localized with FRCs. Aged FRCs extended marginally into B cell follicles, and may
contribute to the blending of the T cell zone and B cell follicles in aged spleens. The described
age-related changes in FRCs number and function may be an underlying factor contributing to
impaired immune system function with age.

INTRODUCTION
Organization is a frequently overlooked component of an effective immune response1. The
likelihood of low frequency antigen-specific T cells2–4 interacting with the antigen presenting cell
displaying their cognate antigen is amplified by multiple layers of organization, including
secondary lymphoid organs. The spleen is one such organ located in the upper right portion of
the abdomen5. The spleen is attached to the vasculature6 and is an important defense against
blood-borne pathogens like encapsulated bacteria7,8. Blood enters into the spleen through blunt
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ended central arterioles which empty into the marginal sinus surrounding the splenic white pulp6.
From the marginal sinus, immune cells can use bridging channels to enter into the T cell zone9.
The T cell zone is surrounded by highly segregated B cell follicles, in which germinal centers can
develop and promote the production of high affinity class-switched antibody responses10,11.

Non-hematopoietic stromal cells provide the framework and directional cues to optimize the
organization of immune cells in the splenic white pulp12–14. Fibroblastic reticular cells (FRCs) are
the most abundant variety of stromal cell in the splenic white pulp15. These cells form a lattice-like
conduit network in the bridging channels and T cell zone upon which antigen, lymphocytes and
dendritic cells traffic14,16,17. FRCs produce homeostatic chemokines, CCL19 and CCL21 which
bind to CCR7 expressing cells to direct them into the T cell zone18–20. FRCs are identified by their
expression of the mucin podoplanin (PDPN), lack of expression of the vasculature marker CD31,
and lack of hematopoietic lineage maker CD4521,22. A specialized subset for FRCs called follicular
dendritic cells (FDCs) are located in the B cell follicles. FDCs produce the chemokine CXCL13
which interacts with CXCR5 on B cells and T follicular helper cells to direct them to the B cell
follicle23. FDCs also trap antigen and provide cues to help B cells in the production of high affinity
antibodies24–26.

It is well established that aging leads to disorganized splenic architecture, characterized by
merging of cells in the B cell follicles and T cell zone27–31. Yet it is less clear how aging impacts
the stromal cells underlying this organization32. While several studies have described age related
attrition of FDC function and morphology33–36, it largely remains to be determined how aging
impacts splenic FRC. In this study, we sought to characterize how aging impacts the number,
morphology and function of splenic FRCs to further our understanding of the aging immune
system.

76

Our results show that aged spleens have fewer FRCs and a decreased T cell zone FRC area.
Concomitant with the reduction of FRCs number, homeostatic chemokine levels are reduced in
aged spleens correlating with impaired recruitment of young T cells. Interestingly, CCL21 largely
co-localizes with FRCs and appears to extend slightly into the B cell follicles in aged but not young
spleens. Reduction of FRC number and homeostatic chemokine concentrations may contribute
to altered splenic architecture and impaired T cell homing found in aged spleens.

MATERIALS AND METHODS
Mice
Aged (18-20 months) male C57BL/6J mice were obtained from the National Institute of Aging
(NIA) aging colony at Charles River Laboratories. Young male C57BL/6J mice (2-4 months) were
obtained from Jackson Laboratories. All mice were kept under specific pathogen free conditions
in sterilized, individually ventilated, HEPA-filtered cages. Mice were sacrificed by CO2
asphyxiation. The Institutional Animal Care and Use Committee at UConn Health reviewed and
approved all experimental procedures using animals.
ELISA
Spleens were harvested, flash frozen and stored at -80oC. Spleens were homogenized in 1ml of
TPER (Thermofisher) with 5μM EDTA (Invitrogen) and 1x HALT protease and phosphatase
inhibitor cocktail (Thermofisher). Homogenates were centrifuged at 1000g for 10 minutes and
supernatants were aliquoted and frozen at -80oC until analysis. CCL21 was measured using
mouse CCL21/6kine DuoSet ELISA (R&D Systems). CCL19 was measured using mouse
CCL19/MIP-3 beta DuoSet ELISA (R&D Systems). Chemokine concentrations were normalized
to total protein concentration determined using Pierce BCA Protein Assay (Thermofisher).
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T cell Transfer
CD8+ T cells were isolated from pooled spleens and lymph nodes of CD45.1+ F5 RAG KO mice
using MojoSortTM Mouse CD8 T cell isolation kit (Biolegend) according to the manufacture’s
instructions. Before transfer, the purity of the isolated CD8+ T cells was confirmed at 85% or
above. 2.3x106 CD8+ T cells in 200µl PBS were tail vein injected into each mouse, which were
sacrificed exactly 30 minutes after transfer for splenic removal.
Immunofluorescence
Spleens were fixed overnight in medium containing 0.05 M phosphate buffer, 0.1 M l-lysine, pH
7.4, 2 mg/ml NaIO4, and 10 mg/ml paraformaldehyde then dehydrated with 30% sucrose in
phosphate buffer. Spleens were frozen in Tissue-Tek O.C.T. compound (Sakura Finetek) and
20μm sections were cut using a CM1850 cryostat (Leica). Sections were blocked for 30 minutes
with 2% goat serum, stained overnight at 4oC in a humidified chamber with primary antibody
cocktail (anti- PDPN clone 8.1.1 unconjugated (Origene) 1:300 dilution, anti-B220 PE-Dazzle
AF594 clone RA3-6BP (Biolegend) 1:100 dilution, anti-CD31 AF647 clone MEC13.3 (Biolegend)
1:100 dilution, anti-CD8α BV421 clone 53.6.7 (Biolegend) 1:100 dilution in 2% goat serum,
washed in PBS then stained for 2 hours at room temperature with secondary antibodies (goat
anti-hamster AF488 (Invitrogen) 1:400 dilution). For detection of CCL21, sections were blocked
as described and stained overnight with biotinylated anti-CCL21 antibody (R&D) (1:20 dilution) in
2% goat serum with 0.3% Triton X-100 (Sigma). After PBS washes, CCL21 signal was amplified
using Alexa Fluor™ 594 Tyramide SuperBoost™ Kit, streptavidin (ThermoFisher Scientific)
according to manufacturer’s instructions. After staining, slides were mounted with Immu-Mount
(Thermo Sceintific) and cover-slipped. Images were acquired using the Zeiss 780 laser scanning
microscope (Carl Zeiss; air objective 20× Plan-Apochromat with NA 0.5 or water objective 10x CApochromat NA 0.45) using multichannel frame scans. The ZEN Black software (Carl Zeiss) was
used for image acquisition. For full spleen images, the ZEN Black tile scan function was used to

78

stitch individual 10x images together. PDPN area was quantified by creating an isosurface of the
staining of 20x images and image processing was performed using Imaris 8.1 software
(BITPLANE).

Splenic Stromal Cell Digestion/Flow Cytometry
To quantify the number of stromal cells in the spleen by flow cytometry, spleens were cut into
2.5mm pieces then enzymatically and mechanically digested as previously described37. The
chopped spleens were placed in 2 ml of enzyme mix composed of RPMI with 0.2mg/ml of
Collagenase P (Roche), 0.8mg/ml Dispase II (Roche) and 0.1mg/ml DNAse 1 (Sigma) and
incubated for 20 minutes in a 37oC water bath (inverting every 5 minutes). The chopped spleens
were gently pipetted up and down three times using a 1 ml pipette tip. The fragments were allowed
to settle for 30 seconds and the supernatant containing the cells released by digestion were
collected into a tube containing 10 ml of ice cold FACS buffer made from 2% FCS, 5mM EDTA
and PBS and centrifuged for 4 minutes at 300g and 4oC. Two ml of freshly prepared enzyme mix
was added to the pellet and incubated for an additional 10 minutes in the 37oC water bath. The
spleens were then vigorously pipetted for 30 seconds using a 1 ml pipette tip. Fragments were
again allowed to settle for 30 seconds and the digested cells in the supernatant were added to 10
ml of FACS buffer and centrifuged. Two ml of new enzyme mix was added to the pellet and then
incubated in the 37oC water bath. Every five minutes until the spleens were completely digested
(no visible aggregates), the cells were vigorously pipetted for 30 seconds. On average, the aged
spleens took about 5 to 10 minutes longer to digest than the young spleens. Red blood cells were
lysed for five mins at RT in ACK lysis buffer (ThermoFisher Scientific). After digestion cell number
and viability were quantified using the Cellometer Auto2000 (Nexcelom Biosciences) with AOPI.
Five million viable splenocytes were stained for flow cytometric quantification of splenic stromal
cell populations. Cells were stained in an antibody cocktail of 100µl in FACS buffer (anti-
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CD16/CD32 clone 93 Fc block unconjugated (ThermoFisher), anti-PDPN Alexa Fluor 594 clone
8.1.1 (Biolegend), anti-CD45 PerCPcy5.5 clone 30F-11(Biolegend), anti-CD31 APC clone
MEC13.3 (Biolegend), Carboxylic Acid Succinimidyl Ester AlexaFluor 350 (Life Technologies).
Fluorescence minus one controls were created for each antibody and used to set gates for
analysis. Without fixation, samples were acquired immediately on an LSRII flow cytometer (BD).
Flow cytometry data analysis was performed using Flowjo software (Tree Star).
Statistical Analysis
Data was tested for normality using the F test. For normally distributed data an unpaired two tailed
T test was used to determine significance. For data with unequal variances, analysis was
performed using the Mann-Whitney Test. Significance was set at p<0.05. Statistical analysis was
performed using GraphPad Prisim 6 software.

RESULTS
Reduction of FRC numbers in aged naïve spleens
Despite the well characterized disruption of splenic white pulp architecture with age, it is unclear
how aging impacts splenic stromal cell numbers and function. We first sought to quantify the
number of stromal cells in both young and aged spleens. Using a rigorous mechanical and
enzymatic digestion, stromal cells were isolated out of spleens and quantified using flow
cytometry. No significant differences were found in either the total number of cells (Fig. 13A) or
CD45- stromal cells (Fig. 13C) in young and aged spleens. Interestingly, aged spleens had
significantly fewer FRCs (Fig. 13D) as gated in Figure 13B. Although flow cytometry is a powerful
tool, digestion of stromal cells from spleens is an imperfect method and may underrepresent the
true number of cells present. To further validate the reduction of FRC numbers in aged spleens
quantitative confocal microscopy was employed.
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Figure 13. Reduction of fibroblastic reticular cell number in aged spleens. Spleens were
mechanically and enzymatically digested to liberate stromal cells for flow cytometric
quantification. A. Total number of nucleated cells in young and aged spleens. B. For quantification
of total splenic stromal cells by flow, samples were gated on alive, single cells that were CD45(left). FRCs were further gated as PDPN+ CD31- (right). C. Number of CD45- cells in young and
aged spleens. D. Number of FRCs in young and aged spleens. Statistical significance was
determined by two tailed T test A,D or Mann-Whitney Test C. *p<0.05. Error bars =+SEM. Data
are combined from three independent experiments n=7-8 mice per group.

T cell zone FRCs were identified by their expression of PDPN (Fig. 14A left and their localization
under CD8+ T cells and surrounding B cells (Fig. 14A right). A digital isosurface rendering of the
PDPN staining was created using Imaris Imaging software (Fig. 14A middle). Quantification of the
PDPN isosurface revealed that the area of aged splenic FRCs in the white pulp were smaller than
their young counterparts (Fig. 14B), confirming flow cytometric quantification. Full spleen images
(Fig. 14C) provide further support to the reduction of FRC area in aged spleens.
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Figure 14. Smaller T cell zone FRC areas in aged spleens. A. Image analysis pipeline for
splenic FRC quantification. Representative images from Young (top) and aged (bottom) splenic
white pulp. FRCs were identified by expression of PDPN (left). A digital rendering of the PDPN
staining was created using Imaris isosurface function (middle). Combined image of CD8α (yellow),
B220 (blue), CD31 (red), PDPN (green) (right). Scale bar= 50µm. B. PDPN area quantification
was accomplished by averaging the area of four different white pulp 20x z stack images (1µm
step size, four steps) per mouse (6 mice per group) C. Longitudinal images of entire spleens from
naïve young (top) and aged (bottom) mice. Scale bar =200µm. Data are representative of n=6
mice per group. Statistical significance was determined by two tailed T-test **p<0.01. Error bars
=+SEM.
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Attrition of aged splenic FRC function
FRC produced homeostatic chemokines CCL19 and CCL21 are important cues directing the
localization and entry of immune cells into the T cell zone of the splenic white pulp18–20. It has
been previously reported that young CD4+ T cells have reduced recruitment into aged spleens
compared to young spleens after antigen challange27,38. In order to determine the impact of aging
on CD8+ T cell recruitment, we transferred young T cells into young and aged hosts and examined
homing after 30 minutes, a time point where exit was unlikely7 (Fig. 15A, B). We found a similar
reduction in the frequency (Fig. 15C) and number (Fig. 15D) of young CD8+ T cells transferred
into aged mice when compared to young mice, but it remains unclear how aging impacts the
concentrations and localization of homeostatic chemokines, important for recruitment of T cells
into the spleen. Quantification of CCL21 (Fig. 15E) and CCL19 (Fig. 15F) protein levels from
homogenized spleens revealed a reduction in the concentrations of both chemokines in aged
spleens compared to young. Thus, the reduced homeostatic chemokine concentrations in aged
spleens may contribute to the impaired recruitment of young CD8+ T cells from the vasculature
into aged spleens.
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Figure 15. Reduced homeostatic chemokines in aged spleens correlate with impaired
recruitment of young T cells. The ability of aged and young spleens to recruit young T cells was
tested using the experimental design outlined in A. B. Transferred young T cells were identified
in young or aged spleens by gating on lymphocytes, single cells, viable cells, CD45+, and
CD8α+CD45.1+. C. Frequency and D. number of young transferred CD8+ T cells in young or
aged spleens. E. CCL21 and F. CCL19 levels were quantified in homogenized naïve spleens and
normalized to total protein. B, C, D Data are one representative experiment of three performed
independently, n=4-5 mice per group. E, F Data are pooled from two independent experiments,
n=18-20 mice per group. Statistical significance was determined by two tailed T-test *p<0.05,
****p< 0.0001. Error bars =+SEM.
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We have previously showed that in aged spleens after challenge with OVA protein and alum
adjuvant, CCL21 localization is altered; spreading from the T cell zone into the B cell follicles27.
Since antigenic challenge has been shown to dramatically alter homeostatic chemokine
concentration and localization39, we next sought to determine where CCL21 localized in young
and aged spleens at homeostasis. Due to low concentrations, CCL19 was not detectable by
microscopy in young or aged spleens, even with the use of amplification reagents (data not
shown). CCL21 in both young and aged spleens localized with PDPN+ T cell zone FRCs (Fig 16.
A,C). Aged FRCs appeared to extend marginally into the B cell follicles, where there was less
overlap in young spleens (Fig. 16 A,C). Of note, despite blocking some nonspecific punctate
background staining for CCL21 was found in the splenic red pulp surrounding the B cell follicles
(Fig. 16B). These data suggest that aging reduces FRC produced homeostatic chemokine
concentration, which localize near FRCs, and may contribute to the reduced recruitment of young
T cells into aged spleens.
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Figure 16. CCL21 localizes to T cell zone FRCs in young and aged spleens. A.
Representative images of young (top) and aged (bottom) splenic white pulp, showing the
localization of CCL21 to the T cell zone, where FRCs localize. B. Negative controls for PDPN and
CCL21 staining. Insert in A is magnified in C. and co-localization of CCL21 and PDPN is shown
in white (far right). Representative images from two independent experiments with n=3 mice per
group. Scale bar=50µm

DISCUSSION
Aging is a multifactorial process that has profound effects on immune system function. Despite
the extensive characterization of the aging immune system, many facets have yet to be rigorously
cataloged and described. Several reports have implied that the “environment” of aged secondary
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lymphoid organs hinders the development of robust T cell responses31,38,40,41. We have previously
reported that young ovalbumin-specific CD4+ T cells transferred into aged hosts have delayed
proliferation, reduced expansion and impaired differentiation into T follicular helper cells
compared to those transferred into young hosts, following OVA immunization27. In the aged hosts,
the donor cells had impaired localization to the splenic T cell zones of the white pulp 18 hours
after immunization. This was in part due to altered localization of CCL2127. Although this report
hinted at FRC dysfunction, it was not directly examined. We also found that aged splenic
environment is rich in active TGF-β and promotes the differentiation of young CD4+ T cells into
of regulatory T cells, which may contribute to impaired T cell and B cell immunity31.

Studies have shown similar findings for young CD8+ T cells transferred into aged mice. Young
influenza specific Clone 4 CD8+ T cells, when transferred into young or aged hosts that had been
intravenously infected with influenza virus, had reduced expansion and decreased interferon
gamma production in aged spleens42.

Another study found that after intravenous Listeria

infection, young CD8+ T cells transferred into aged mice had reduced expansion in the spleen.
This study linked poor CD8+ T cell responses to reduced CD8α dendritic cell responses, and did
not consider the implications of the disorganized splenic architecture or stromal cell dysfunction40,
In this current study, we sought to directly examine how aging impacts one component of the
splenic microenvironment, stromal cells. The disorganized architecture of the splenic white pulp
lead us to hypothesize that aging may influence FRC number and function, due to their important
role orchestration of splenic architecture15,18.

We found that aged spleens had fewer FRCs, which results in smaller FRC area in the T cell zone
of the splenic white pulp. We also described how aged spleens have decreased concentrations
of homeostatic chemokines CCL19 and CCL21 which is corroborated by previous studies27. We
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found that CCL21 localizes near FRCs which extend marginally into the B cell follicles of the aged
splenic white pulp and may contribute to architectural disruption. CCL21 localization in aged
spleens at homeostasis did not appear to be as dramatically altered as previously reported after
antigenic challenge, which may correlate with more dramatic changes in architecture after
challange27. We also found that decreased homeostatic chemokine concentrations also correlated
with reduced homing of young T cells into aged compared to young spleens. Along with reductions
in CCL19 and CCL21 concentrations, other alterations in aged spleens, like changes to splenic
arteries may contribute to T cell homing defects, and remain to be examined.

FRCs are functionally important for the organization of the splenic white pulp, but are most likely
only one component contributing to the age related changes in the spleen. Changes in chemokine
receptor expression on immune cells and their ability to respond to chemotactic gradients has
also been observed and may add to altered architecture31,43–47. The mechanism behind why there
are fewer FRCs in aged spleens also remains to be determined. One possible explanation may
be that there are interruptions to important maintenance signals via lymphotoxin beta receptor 48–
52

. If aging impacts lymphotoxin beta-receptor expression on stromal cells or lymphotoxin beta

expression on immune cells remains to be determined.

Apart from their role in architectural organization, recent studies have elucidated roles for
fibroblastic reticular cell in the control53,54, survival55,56 and initiation57 of T cell responses. It
remains to be determined if aging impacts any of these functional attributes of FRCs. Whether
lymph node stromal cells experience similar changes to splenic stromal cells also remains
unclear36,58,59. On a broader scale, it also remains to be determined if splenic and lymph node
fibroblastic reticular cells are of similar origin and composition. Erosion of secondary lymphoid
organ stromal cell function may have far-reaching effects on multiple facets of the aged immune
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system and, despite the advances make in this manuscript, we are still in the infancy of
understanding how aging impacts these cells.
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CHAPTER 4
Assessment of lymph node stromal cells as an underlying factor in age
related immune impairment to influenza infection
ABSTRACT
It is well established that aging negatively impacts immunity, resulting in inefficient responses to
vaccinations and infections, such as influenza. Fibroblastic reticular cells (FRCs) are the major
stromal cell subset in lymph nodes (LN) and play an intricate role in the orchestration and control
of adaptive immune responses. Although stromal cells have a major impact on immune
responses, the impact of aging on LN stromal cells has yet to be determined. We sought to
determine how aging impacts FRC number, phenotype and morphology at steady state and after
influenza infection. Quantitative analysis of lymph node stromal cells by flow cytometry revealed
that there are no significant differences in the number stromal cells in young and aged lymph
nodes at steady state, but after influenza infection aged FRCs have delayed expansion. Reduced
proliferation of aged FRCs, but not increased death, results in this decreased expansion. Aged
LNs also exhibited reduced concentrations of FRC produced homeostatic chemokines,
correlating with reducing homing of naïve T cells. Image analysis of lymph nodes revealed that
young and aged T cell zone FRCs have similar morphology at both steady state and after
infection. In addition, aged FRCs did not appear to be a contributing factor in the reduced
proliferation of young T cells transferred into aged LNs after influenza infection. These results are
the first evidence that aging alters lymph node stromal cells ability to respond to challenge and
functionality. Furthermore, these changes in aged FRCs may be an underlying contributor to the
impaired immune response to influenza infection found in the elderly.
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INTRODUCTION
Influenza is a highly problematic and often lethal infection for elderly populations1,2. Decline of
immune system function, collectively termed “immunosenesence”, contributes heavily to the
increased susceptibility of the elderly to influenza3. Intrinsic defects in adaptive immune cells have
been well characterized, with strong focus on cells of the T cell lineage4,5. Both CD4 and CD8+ T
cell responses to influenza infection are altered with age. Aged mice have delayed influenza
nucleoprotein (NP) specific CD4+ T cells responses in their lungs compared to young mice6.
Concomitantly, influenza NP specific CD8+ cell responses are reduced in the lungs of aged mice
after influenza infection7. This correlates with the delayed clearance of virus from aged lungs8,9. It
is possible that changes in secondary lymphoid organs may exacerbate problems with T cell
immunity and age.

Adoptive transfer studies have been the key to dissecting the impact of the aged environment on
T cell mediated responses. In these studies, young T cells with full functional capacity are
transferred into either young or aged hosts, which are subsequently challenged and the response
of the transferred T cells is analyzed. This approach tests the influence of T cell independent
factors in the secondary lymphoid organ microenvironment on the development of antigenspecific T cell responses. These studies have provided striking insight into the deleterious impact
of the aged secondary lymphoid organ environment on T cell responses. Several studies have
shown that young T cells have delayed entry, priming and reduced function in aged compared to
young lymph nodes and spleens after challange10–12. Yet is remains to be determined which
factors in the aged secondary lymphoid organs hinders young T cell responses.

Stromal cells in secondary lymphoid organs such as lymph nodes, are non-hematopoietic cells of
mesenchymal origin13. These cells were once thought to solely function as the structural skeleton
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of lymph nodes, mediating architectural organization, but are now appreciated to be involved in
many aspects of both innate and adaptive immune responses14–16. In lymph nodes there are four
major subsets of stromal cells, fibroblastic reticular cells (FRCs), lymphatic endothelial cells
(LECs), blood endothelial cells (BECs) and double negative cells (DNCs). LECs and BECs line
lymphatic and blood vessels respectively, functioning to facilitate transport of fluid, cells and
antigen into and out of lymph nodes17,18. DNCs are a rare and poorly understood subset of lymph
node stromal cells that are thought to be contractile FRC like pericytes19. FRCs are the major
stromal cell subset of the lymph node and play an intimate role in the initiation, orchestration and
control of adaptive immune cell functions16,20. At homeostasis, FRC produced CCL19 and IL-7
promote the survival of naïve T cells25. With regards to influenza infection, Denton et al
demonstrated that lymph node FRCs are required to initiate adaptive immunity to influenza
infection21. FRCs produce homeostatic chemokines (CCL19 and CCL21) that recruit and position
lymphocytes and dendritic cells in lymph nodes22,23. FRCs also create a conduit network
controlling the migration of T cell, dendritic cells and antigen in the lymph node paracortex and
medulla24. During the response to an infection, FRCs have been shown to elongate and expand,
which is thought to increase space for the immune response to occur26–28. Apart from enhancing
immune cell interactions and survival, FRCs have been shown to control T cell mediated
immunity, though a NOS2 dependent pathway29–31.

Despite the in depth involvement of FRCs in development and control of T cell mediated immunity,
it is unclear how aging impacts the numbers and function of these cells32–34. We hypothesize that
FRCs in aged lung draining, mediastinal lymph nodes (MLN), are an underlying factor in the
attrition of T cell responses to influenza infection in aged mice. In this study, we rigorously
characterize how aging impacts FRC number and morphology at homeostasis and during
influenza infection. We also determine how aging impacts FRC functional ability to produce

97

homeostatic chemokines, important for T cell recruitment into the lymph node and tested the
ability of aged FRCs to inhibit T cell proliferation.

We determined that at homeostasis young and aged MLNs have similar numbers of FRCs, but
after infection aged FRCs take longer to peak in number in part due to decreased proliferation.
Aged FRCs appear to be functionally deficient, with decreased CCL19 and CCL21 concentrations
in aged MLNs at homeostasis that fail to dip after infection as is seen in young MLNs. Importantly,
the decreased CCL19 and CCL21 concentrations correlate with reduced homing of young donor
T cells into aged MLNs when compared to young MLNs. We also found that young influenza NP
specific CD8+ T cells exhibit reduced activation and proliferation in aged compared to young
MLNs. Yet from in vitro experiments, it appears as though aged FRCs maintain their ability to
inhibit T cell proliferation and may not be the cause the in vivo T cell proliferation deficit. This
research expands our understanding of the aged immune system and provides new insight into
the biology of aging stromal cells.

MATERIALS AND METHODS
Mice/Infection
Young (2-4 month) male C57BL/6 mice were acquired from Jackson laboratories. Aged (19-21
month) male C57BL/6 mice were acquired from National Institute of Aging’s colony at Charles
River Laboratories. F5 RAG KO TCR transgenic (TCR specific for NP of H17 influenza) mice were
received as a generous gift from Dr. Linda Cauley at the University of Connecticut School of
Medicine and were used in experiments at two months of age. Mice were housed under specific
pathogen free conditions in sterilized, individually vented, HEPA filtered cages in the UConn
Health animal facility. Mice were infected via intranasal administration with sublethal doses of
either 400EID50 PR8 influenza or 600EID50 E61-13-H17 (H17) influenza. After infection, mice were
monitored daily and sacrificed if they showed visible signs of distress or if their weight dropped
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below 70% of their starting weight. Mice were sacrificed at time points listed after infection using
CO2 asphyxiation. The UConn Health Animal Care and Use Committee reviewed and approved
all experimental procedures using animals.
Lymph Node Stromal Cell Digestion/ Flow Cytometry
Lymph nodes from individual mice were dissected and placed in RPMI-1640 on ice until digestion.
Lymph nodes were placed into 5 ml Eppendorf tubes with 2 ml of freshly made enzyme mix
comprised of RPMI-1640 containing 1.3 U/ml Liberase TL (Sigma) and 300U/ml of
Benzonuclease (Millipore Sigma). Tubes were incubated at 37°C in a water bath and gently
inverted at 5 min intervals. After 20 minutes, lymph nodes were very gently pipetted up and down
once using a 1-ml pipette, which disrupting the capsule. The tubes were placed back into the
water bath and fragments were allowed to settle for 30 seconds. Subsequently, the enzyme mix
was removed and added to 10 ml of ice-cold FACS buffer (2% FCS, 5 mM EDTA in PBS) and
centrifuged (300 g, 4 minutes, 4°C). Two milliliter of fresh enzyme mix was added to the digestion
tube. After 10 minutes, the cells were mixed vigorously for 30 seconds using a 1-ml pipette.
Fragments were again allowed to settle, the supernatant was removed and added to the
previously spun cell pellet in FACS buffer. Two ml of fresh enzyme mix was added to the digestion
tube. Until the digestion was completed, the samples were vigorously pipetted with a 1-ml pipette
every 5 minutes until, when held up to light, no lymph node fragments were visible. In general, the
aged lymph nodes took about five minutes longer to digest then young lymph nodes.
Supernatants were centrifuged after each removal (300 g, 4 min, 4°C) until finally, each collection
tube contained the entire cellular contents of an individual mouse’s harvested lymph nodes. Cells
were filtered through 100 μm nylon mesh, counted and assessed for viability using AOPI on the
Cellometer cell counter (Nexcelom). For staining of surface antigens only, 5 × 106 cells per sample
were then incubated with 100 μl diluted antibodies for 20-30 min at 4°C in ice-cold FACS buffer
before acquisition on the flow cytometer, without fixation. For measurement of stromal cell
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proliferation, intracellular Ki67 was assessed using Foxp3 Fix/Perm kit (eBioscience) according
to manufacture’s instructions. For measurement of death in stromal cell populations, cells were
stained in Annexin V Binding buffer (BD Biosciences) according to manufacture’s protocol.
Peripheral blood was acquired by cardiac puncture and red blood cells were lysed using ACK
lysis buffer (Life Technologies). Surface antigens on peripheral blood cells were stained as
described above. To quantify cell numbers in peripheral blood, CountBright Absolute Counting
Beads (ThermoFisher) were used according to manufacture’s instructions. Antibodies used are
listed in Table 3. Samples were acquired on a LSRII flow cytometer (BD Bioscience) and analysis
was performed using Flowjo software v10 or v7.6.5 (Tree Star).
Table 3. Antibodies used for flow cytometry of stromal cells
Antibody
Fluorophore
Clone
CD45
PerCPCy5.5
30-F11
PDPN
PE-Cy7
8.1.1
BV510
CD31
AF647
MEC13.3
TER-119
CD21/CD35
Annexin V
CD8α
CD45.2
CD45.1
CD69
CD44

APC-Cy7
BV421
BV711
BUV737
PerCpCy5.5
APC
BV421
BV650

TER-119
7E9

NOS2

AlexaFluor®488

C-11

Ki67
Carboxylic Acid, Succinimidyl Ester
(Live/Dead Indicator)
CD16/CD32
(Fc Block)

PE

SolA15

53-6.7
104
A20
H1.23F
IM7

AlexaFluor®350
Unconjugated

Manufacturer
BD
Biolegend
BD
Biolegend
Biolegend
Biolegend
BD
BD
BD
BD
BD
Biolegend
Santa Cruz
Biotechnology
eBioscience
Life Technologies
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eBioscience

Immunofluorescence
Mediastinal lymph nodes were fixed overnight in medium containing 0.05 M phosphate buffer, 0.1
M l-lysine, pH 7.4, 2 mg/ml NaIO4, and 10 mg/ml paraformaldehyde then dehydrated with 30%
sucrose in phosphate buffer. Lymph nodes were frozen in Tissue-Tek O.C.T. compound (Sakura
100

Finetek) and 20μm sections were cut using a CM1850 cryostat (Leica). Sections were blocked for
30 minutes with 2% goat serum, stained over night at 4oC in a humidified chamber with primary
antibody cocktail, washed in PBS and then stained for 2 hours at room temperature with
secondary antibodies. For detection of CCL21, sections were blocked as described and stained
overnight with anti-CCL21 in 2% goat serum with 0.3% Triton X-100 (Sigma). After PBS washes,
CCL21 signal was amplified using Alexa Fluor™ 594 Tyramide SuperBoost™ Kit, streptavidin
(ThermoFisher Scientific) according to manufacture’s instructions. Antibodies used for
immunofluorescence are listed in Table 4. Slides were mounted with Immu-Mount (Thermo
Sceintific), cover slipped and sealed. Images were acquired using the Zeiss 780 laser scanning
microscope (Carl Zeiss; air objective 20× Plan-Apochromat with NA 0.5 or water objective 40x CApochromat NA 1.2 with 1.5 digital zoom) using multichannel frame scans. The ZEN Black
software (Carl Zeiss) was used for image acquisition. For full lymph node images, the ZEN Black
tile scan function was used to stitch individual 20x images together. For ER-TR7 analysis three
z-stack (4-1um steps) images per mouse were acquired of the T cell paracortex with the 40x
objective. Volume and disconnection of ER-TR7 network was quantified using the isosurface tool
in Imaris 8.1 software (BRITPLANE). Network length and brank point analysis was quantified
using the filament tracer tool in Imaris 8.1 software.
Table 4. Antibodies used for immunofluorescence of stromal cells
Antibody
Fluorophore
Clone
Manufacturer
1o ER-TR7
Unconjugated Rat
ER-TR7
Acris
2o Goat-anti-Rat
AlexaFluor568
Invitrogen
B220
PE-Dazzle
RA3-6B2
Biolegend
CD31
AlexaFluor647
MEC13.3
Biolegend
Lyve-1
AlexaFluor488
ALY7
eBioscience

T Cell Transfer
CD45.1+ CD8+ T cells were isolated from pooled spleens and lymph nodes of F5 RAGKO mice
using Mojosort Mouse CD8 T cell isolation kit (Biolegend) according to manufacture’s instructions,
with an ending purity of >90% (data not shown). To measure T cell proliferation in vivo, isolated
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F5 T cells were labeled in PBS with 5μM CFSE for 10 minutes at 37oC then washed in PBS with
10% FCS. 8x105 CFSE+ CD45.1+ F5 CD8+ T cells were tail vain injected in 200μl of PBS into
each mouse, and then rested overnight before infection with H17 influenza the next morning. To
assess T cell entry into lymph nodes, 2.3x106 CD45.1+ CD8+ F5 T cells in 200μl of PBS were tail
vein injected into recipient young or aged recipient mice. Recipient mice were then sacrificed
exactly 30 minutes after transfer. Blood (cardiac puncture) and MLN were collected for flow
cytometric analysis from those mice.
CCL19/CCL21 ELISA
MLNs were dissected, flash frozen and stored at -80oC. MLNs were homogenized in 400μl of
TPER with EDTA (Invitrogen) and HALT protease and phosphatase inhibitor cocktail
(Thermofisher), and then centrifuged at 1000g for 10 minutes. Supernatants were aliquoted and
frozen at -80oC until analysis was performed. CCL21 was measured using mouse CCL21/6kine
DuoSet ELISA (R&D Systems) according to manufactures instructions on MLN homogenates
diluted 1:3 in reagent diluent. CCL19 was measured using mouse CCL19/MIP-3 beta DuoSet
ELISA (R&D Systems) according to manufactures instruction on undiluted MLN homogenates.
Chemokine concentrations were normalized to total protein concentration determined using
Pierce BCA Protein Assay (Thermofisher).
FRC Mediated T cell Proliferation Inhibition Assay
Lymph nodes were harvested and pooled from either 10 young or 10 aged mice. Stromal cells
were liberated by sterile digestion in 5 ml of enzyme mix per sample as described above. Total
lymph node digested samples were cultured at 5x105 cells per cm2 in αMEM with 10% FCS and
1% ABAM (Life Technologies). After 24 hours, non-adherent cells were removed and new media
was added to the cultures. After five additional days of culture, cells were harvested with 0.2%
trypsin, 5mM EDTA in PBS. LECs and BECs were removed from the harvested population by
staining with anti-CD45 PE (Clone 30-F11) (BD) and anti-CD31 PE (Clone MEC13.3) (BD),
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followed by anti-PE microbeads isolation (Miltenyi). FRC purity was confirmed at >90%. 5x104
FRC per well were plated in a flat bottom 96 well plates and rested overnight. The next day, CD8+
T cells were isolated from young C57BL/6 mice and labeled with CFSE as described above, with
>90% purity. 5x105 CFSE labeled CD8+ T cells were added to wells with or without young or aged
FRCs. To stimulate the CD8+ T cells in vitro, anti-CD3, anti-CD28 Dynabeads (ThermoFisher)
were added at a 1:1 bead to T cell ratio to wells with or without FRCs. After 48 hours, T cells were
removed from culture and proliferation was measured by flow cytometric examination of CFSE
dilution. Division index, the average number of cell divisions that a cell in the original population
has undergone, was calculated using Flowjo’s proliferation tracker tool. Culture supernatants
were also collected and nitric oxide was measured using the Greiss Reagent system (Promega)
according to manufacture’s instructions.
Statistical Analysis
Statistical significance was determined by Student’s t test, One way or Two way ANOVA,
Repeated Measures ANOVA or Mantel Cox Log Rank Test as specified in the figure legends.
Statistical analyses were performed with Prism 6 software (GraphPad Software). Differences
were considered significant at p<0.05.
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RESULTS
Altered kinetics of aged lymph node stromal cell expansion
To evaluate if stromal cells are an underlying contributor to impaired immune responses during
influenza infection in aged mice, we first sought to determine how stromal cells respond in
young and aged mice. Young and aged mice were infected with PR8 influenza (Fig. 17A). In
agreement with previous reports, aged mice had decreased survival (Fig. 17B) and increased
weight loss (Fig. 17C) after infection compared to young8,9.

Figure 17. Aged mice have decrease survival and increased weight loss after sub lethal
infection with influenza. A. Experimental design: Young and aged mice were infected with a
sub-lethal dose of PR8 influenza infection and sacrificed at time points listed for analysis. B.
survival C. weight loss was quantified. Data are from one representative experiment of at least
four experiments performed independently. Statistical significance was determined by B. Mantel
Cox Log Rank Test or C. Repeated measures Two Way ANOVA with Sidak multiple comparison.
**p<0.01, ****p<0.0001. Error bars= +SEM.

In order to determine how aging impacts the number of stromal cells in lymph nodes, we digested
both the lung draining mediastinal lymph node (MLN) and the non-draining popliteal lymph node
as a control to ensure that digestion was standard across time points. While some reports have
suggested that aged lymph nodes fail to expand to the same extent as young lymph nodes after
immune challenge12, we found that young and aged MLNs expanded with similar kinetics and no
significant difference was observed in total cell number at homeostasis or at any time point after
influenza infection in young and aged MLNs or PLNs (Fig. 18A). In order to quantify lymph node
stromal cell numbers, we used a slightly modified version of Fletcher et al’s protocol for digestion
of lymph nodes for stromal cells20. With minor modifications, we were able to digest lymph nodes
with high viability (Fig. 18B) and achieved similar frequencies of stromal cell populations (Fig.
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18C) to what has been reported in the literature20. Upon quantification of the total number of
stromal cells (CD45-Ter119-) cells in MLNs and PLNs at homeostasis, we did not see any
significant difference in young and aged samples. Interestingly, at day 10 post infection, a
previously reported peak of stromal cell numbers after influenza infection21, we found that aged
MLNs had significantly fewer total stromal cells compared to young MLNs (Fig. 18D). By day 12
post infection, the aged MLN stromal cell numbers were equal to that of the young MLNs,
suggesting a delayed expansion in aged lymph nodes (Fig. 18D). The total stromal cell population
was further differentiated into FRCs (PDPN+CD31-CD21/CD35-), LECs (PDPN+CD31+), and
BECs (PDPN-CD31+). At homeostasis in both MLNs and PLNs all of these populations were not
significantly different in number in young and aged lymph nodes (Fig. 18E,F,G). After infection
there were significantly fewer aged FRCs and LECs at day 10 post infection (Fig. 18E,F) but this
difference was corrected at day 12 post infection when the aged numbers reached that of the
young for both FRCs and LECs (Fig. 18E,F). BECs had different expansion kinetics with their
numbers being similar in young and aged up to day 10 post infection, but higher in aged MLNs at
day 12 post infection (Fig. 18G). Of note, PLN total stromal cell, FRC, LEC, and BEC numbers
were not significantly different from the non-infected time point at any day post influenza infection
(Fig 18. D,E,F,G), confirming that the digestions were consistent and the increase in MLN FRC,
LEC and BEC numbers was not due to a technical artifact. We next sought to determine the
mechanism behind the decreased numbers of FRCs and LECs at day 10 post infection.
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Figure 18. Reproducible, high validity stromal cell digestion reveals altered stromal cell
expansion kinetics in aged mediastinal lymph nodes after influenza infection. A. Total cell
numbers of stromal cell digested MLNs (draining lymph node) and PLNs (non-draining lymph
node) after infection with PR8 as in Fig 1. B. Viability of lymph nodes after stromal cell digestion.
C. Flow cytometric gating strategy for lymph node stromal cell populations in young (top) and
aged (bottom) lymph nodes. Number of D. total stromal cells E. FRCs, F. LECs, G. BECs in young
and aged MLNs and PLNs after influenza infection. Data are pooled from two independent
experiments n=10-18 mice per group, per time point. Statistical significance was determined by
Two-Way ANOVA with Tukey post test. Error bars=+ SEM.
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Decreased proliferation contributes to reduced number of FRCs and LECs after influenza
infection
It is possible that the decreased number of FRCs and LECs at day 10 post infection in aged MLNs
may be due to either decreased proliferation or increased death or a combination of both. Upon
analysis of proliferation, we found that at day 10 post infection, lower frequencies of FRCs (Fig.
19A), LECs (Fig. 19B) and BECs (Fig. 19C) were proliferating in aged MLNs compared to young
MLNs, correlating with decreased cell numbers at this time point. Analysis of cell death in MLN
FRCs (Fig. 19D), LECs (Fig. 19E), and BECs (Fig. 19F) showed no significant differences
throughout the course of influenza infection. These results suggest that the mechanism behind
the decreased number of FRCs and LECs at day 10 post infection is in part due to decreased
proliferation and not increased rate of cell death. Thus, we next wanted to determine if the
structure of the FRC network was altered with age.

107

Figure 19. Decreased proliferation, but not increased death, contributes to reduced stromal
cell numbers in MLNs after influenza infection. Frequency of Ki67+ A. FRC, B.LECs, and C.
BECs after influenza infection in draining (MLN) and non-draining lymph nodes (PLN). The
frequency of apoptotic (Annexin V+, CASE L/D-), necrotic (Annexin V- CASE L/D+) and viable
(Annexin V- CASE L/D-) D. FRCs, E. LECs and F. BECs in MLNs were quantified. Data are
pooled from two independent experiments n=8-10 mice per group per timepoint. Statistical
significance was determined by Two Way ANOVA with Tukey post test. ****p<0.0001. Error bars
=+SEM.

Preserved T cell zone FRC network morphology in aged lymph nodes
It is well accepted that aging disrupts the architectural organization of secondary lymphoid organs.
Several studies have described that aged lymph nodes have poorly defined B cell follicles that
merge into the T cell paracortex12,34,35. To determine if similar architectural disorganization existed
in aged mediastinal lymph nodes at homeostasis and after influenza infection, we performed
confocal microscopy. At homeostasis, we found mild disruption of B cell follicles in aged (Fig. 20
bottom left) compared to young MLNs (Fig. 20 top left). After influenza infection, aged MLNs
showed dramatic loss of B cell follicle organization (Fig. 20 bottom right), while B cells in young
MLNs were confined to well organized follicles (Fig. 20 top right).
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Figure 20. Disrupted lymph node architecture in aged mice after influenza infection. MLNs
from non-infected young mice (top left) display organized B cell follicles, while B cell follicles in
aged MLNs (bottom left) show mild disruption. Fourteen days after influenza infection B cell
follicles in aged MLNs (bottom right) become highly disputed, while young MLN B cell follicles
remain organized (upper right). Images shown are representative of 5 young and 5 aged mice at
each time point from two experiments performed independently. Yellow-B220 (B Cells), RedCD31 (Blood vessels), Blue-Lyve-1 (lymphatic vessels), Purple colocalization of CD31 and Lyve1 (lymphatic vessels). Scale bar= 200µm.

109

FRCs are important for homeostasis and maintenance of B cell follicle organization36. We sought
to determine if the FRC network was preserved in aged lymph node at homeostatic and after
influenza infection. Quantification of the T cell zone FRC network revealed no difference in density
(Fig. 21D), network length (Fig. 21E), connectivity (Fig. 21F), or in the number of branch points
(Fig. 21G) at homeostasis or after influenza infection in young compared to aged lymph nodes.
After influenza infection both young and aged FRC network density (Fig. 21D) and length (Fig.
21F) decreased, supporting previous data that after LPS challenge FRCs become less tense and
elongate37. These data show that the T cell zone FRC network is preserved with age and responds
similarly to influenza challenge. Next, we wanted to determine the effects of aging on FRC
function.
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Figure 21. Aging does not alter T cell zone FRC morphology. A. Representative confocal
image of stromal cells in a young non-infected MLN denoted by ER-TR7 in yellow. The red insert
is an magnification of the T cell zone FRCs, which are quantified in the remainder of the figure.
B. Displays the image analysis pipeline for quantifying the FRC network. Z stack images of 4 one
µm steps were taken using the 40x objective lens of the Ziess LSM780 (Left-staining). Imaris
imaging software was used to create a digital rendering of the staining called an isosurface
(middle) to quantify FRC volume and segmentation. The filament tracer tool in Imaris software
was used to map the FRC network (right) to determine the network length and number of FRC
branch points. C. Representative FRC images from young (top) and aged (bottom) non-infected
(left), day 7 post infection (middle) and day 10 post infection (right) MLNs. No significant difference
was discovered in the FRC volume D, segmentation E, network length F or branch points G in
young and aged mice at steady state and after infection. Statistical significance was determined
using two-Way ANOVA with Tukey post test. *p<0.001. n=10 young, n=10 aged mice per time
point. Data shown are pooled from two experiments performed independently. Error bars= +SEM.
Scale bar=20µm.
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Reduction in homeostatic chemokines and altered HEV architecture correlates with
reduced T cell homing into aged MLNs
FRCs produce homeostatic chemokines CCL19 and CCL21 which facilitate the localization and
homing of CCR7 expressing cells in the lymph node22,23. We wanted to determine if young T cells
had decreased homing into aged compared to young MLNs as previously reported for other lymph
nodes12. We transferred young CD8+ T cells into young and aged hosts and quantified their entry
into MLNs (Fig. 22A). There was a higher frequency (Fig. 22C) and number (Fig. 22D) of young
donor CD8+ T cells in the peripheral blood of aged compared to young hosts. This correlated with
decreased frequency (Fig. 22F) and numbers (Fig. 22G) of donor cells in aged MLN when
compared to young. These data show that there is a lymph node intrinsic defect that results in
decreased recruitment of T cells.

Next, we went on to determine if the decreased T cell entry in aged MLNs correlated with reduced
homeostatic chemokine concentrations. At homeostasis, we found that aged MLNs had
decreased concentrations of both FRC produced homeostatic chemokines, CCL21 (Fig. 22H) and
CCL19 (Fig. 22I). The location of CCL21 appeared to be similar in both young and aged MLNs
and did not extend into the B cell follicles (Fig. 22J). Since FRCs have been shown to respond
to immune challenge by temporarily decreasing their production of CCL2138,39, we went on to
determine if aged FRC responded to infection in a manner similar to young. Three days after
infection, we found that young MLNs decreased their production of CCL21, but aged MLN CCL21
concentration did not change (Fig. 22H). These data show that aged stromal cells produce less
homeostatic chemokines and are less responsive to challenge when compared to young stromal
cells. These changes in FRC function may contribute to reduce homing of young T cells into aged
lymph nodes. We next sought to analyze another component import for T cell entry into lymph
nodes, high endothelial venules (HEV).
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Since HEVs are the physical entry sites for lymphocytes into the MLN17, we assessed if HEV
morphology was influenced by aging. We found that HEVs in aged naïve MLNs appear less
cuboidal and were thinner when compared to those in young MLNs (Fig. 22K, L). Our attempts to
quantify the number of HEVs in naïve MLNs using flow cytometry gave conflicting results, so the
data is not reported here. ICAM-1 is an import adhesion molecule on HEVs and BECs which binds
to LFA-1 on T cells to mediate arrest during transendothelial migration
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. Interestingly we found

no difference in ICAM-1 expression on young or aged BECs (Fig 22. M). These data show
changes in stromal cell function and morphology, which may contribute to impaired homing of T
cells into aged lymph nodes. Thus, we next performed experiments to determine if aged FRCs
contributed to impaired T cell priming in aged lymph nodes.
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Figure 22. Decreased homing of young T cells into aged lymph nodes correlates with
decreased homeostatic chemokines and altered HEV structure. A. Experimental outline for
T cell transfer. B. Representative flow plot, C. frequency, and D. number of young transferred
CD8+ T cells in young or aged blood. E. Representative flow plot, F. frequency and G. number of
young transferred CD8+ T cells in young and aged MLNs. H. CCL21 protein concentration in
naïve and day three post H17 influenza infection MLNs. I. CCL19 protein concentration in naïve
MLNs. J. Naïve MLNs stained for CCL21. K. Representative images of HEVs in naïve MLNs. L.
Quantification of HEV thickness in naïve MLNs. M. ICAM-1 gMFI of BECs from naïve MLNs. AG Data are from one representative of three experiments performed independently, n=4 mice per
group. H, I, Data are pooled from two independent experiments, n=13-20 mice per group. J,K
Representative images from one of n=6-10 mice per group, scale bar =200um. L. Each data point
is the average thickness of three HEVs from one mouse. Each HEV was measured at 5 different
points and the average thickness was taken, n=6-10 mice per group. M. Data are representative
from one of two experiments performed independently n=5-8 mice per group. C,D,F, G, I, L, M
statistical significance was determined by two tailed T-test. I. Statistical significance was
determined by Two-way ANOVA with Tukey post test. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001. Error bars =+SEM.
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Reduced priming of young T cells in aged MLNs
Previous studies have reported defective priming of young T cells in aged inguinal lymph nodes10,
therefore we sought to determine if a similar phenomenon happened to T cells in the MLN in
response to influenza infection. To test this, we used F5 TCR transgenic CD8+ T cells, which
have a TCR specific for the influenza nucleoprotein peptide 366-374 (NP366−374/Db) from the E6113-H17 (H17) influenza virus41. Young CFSE labeled CD45.1+ F5 CD8+ T cells were transferred
I.V. into both young and aged CD45.2+ hosts, which were rested overnight and then infected with
H17 influenza (Fig. 23A). Three days after infection, the response of the transferred cells was
assessed using flow cytometry. The young F5 cells in aged MLNs had reduced proliferation
compared to those in young MLNs (Fig. 23B). Furthermore, fewer F5 cells in the aged host
expressed the activation markers CD69 (Fig. 23C) and CD44 (Fig. 23D) when compared to donor
cells in young hosts. These data show that T cell priming is impaired in aged MLNs after influenza
infection. To examine this further, we tested the hypothesis that FRCs may be the culprit behind
this proliferation defect.
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Figure 23. Reduced proliferation and activation of young influenza specific CD8+ T cells in
aged lymph nodes after infection A. Experimental outline B. CFSE division of young F5 CD8+
T cells in young (grey) or aged (white) mediastinal lymph nodes, three days after influenza
infection with representative flow plot (left) and quantification (right). C. CD69 and D. CD44
expression on young F5+ T cells in young (grey) or aged (white) MLNS. FMOs shown in black.
Data are one representative experiment of two performed independently. n=4-5 mice per group.
Statistical significance was determined by a two-tailed T-test. *p<0.05, **p<0.01. Error
bars=+SEM.
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FRCs maintain their inhibitory capacity with age
FRCs have been shown to reduce the proliferation of T cells in culture via production of nitric
oxide (NO)29. To test the inhibitory capacity of young versus aged FRCs, we used the in vitro
system published by Lukacs-Kornek et al. in which CFSE labeled CD8+ T cells were stimulated
in cultures with or without FRCs29. Since aged T cells have intrinsic proliferation defects, we used
only young T cells in our co-culture system to test the capacity of aged and young FRCs to inhibit
T cell proliferation, with the hypothesis that aged FRCs would be more inhibitory42. Young
stimulated CD8+ T cells had high rates of proliferation as expected (Fig 24. A, B, C). Interestingly,
both young and aged FRCs suppressed the division of these young CD8+ T cells equally (Fig.
24. A,B,C). We also examined whether these cultured young and aged FRCs produced similar
quantities of NO. As reported by Lukacs-Kornek et al, FRCs only produced NO in the presence
of activated T cells, not when they are cultured by themselves (Fig. 24D). Young and aged FRCs
produced equal amounts of NO when cultured with young CD8+ T cells and stimulation (Fig. 24D),
in agreement with their ability to equally suppress T cell proliferation (Fig. 24A,B,C). These
experiments have the major caveat of being in vitro. Changes in aged FRCs may be lost during
culture, so we wanted to determine what was happening in vivo. Therefore, we analyzed the
expression of the protein responsible for NO production in FRCs, NOS2 in both MLNs and PLNs
at homeostasis and after influenza infection29,43,44. We found that both young and aged MLN FRCs
upregulate NOS2 expression after influenza equally, with no age-related differences (Fig. 24E).
These results are in agreement with our in vitro data in that it appears as though aged FRCs
maintain their capacity to suppress T cell proliferation as equally as young FRCs and may
contribute to the reduced T cell proliferation in aged MLNs after influenza via this mechanism.
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Figure 24. Aged FRCs maintain their ability to suppress T cell proliferation Young CFSE+
CD8+ T Cells, with or without anti-CD3, anti-CD28 microbeads, were cultured for 48 hours with
either young FRCs, aged FRCs or no FRCs at a 10:1 ratio (T cell/FRC). The ability of FRCs to
suppress T cell proliferation was measured by CFSE dilution of young CD8+ T cells,
representative flow plots shown in A. B. Division index of CD8+ T cell in the FRC co-culture. C.
Percent of young CD8+ T cells that divided in co-culture. D. Nitric oxide in the co-culture
supernatants was quantified using the Greiss reagent system as Nitrite. E. In vivo NOS2 MFI
was measured on FRCs at homeostasis and after influenza infection in draining (MLN) and nondraining (PLN) lymph nodes. MFI was normalized to FMO at each time point listed. A, B, C, D
Each point represents one experimental replicate, which is the average of three technical
replicates, n=3 experiments. Statistical significance was determined by One-Way ANOVA with
Tukey post test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 E. Combined data from two
experiments performed independently, n=8-16 mice per group. Statistical significance was
determined by Two-Way ANOVA with Tukey post test. No significant differences were found in
young or aged PLNs at any time point tested. **p<0.01, ***p<0.001, ****p<0.001. Error bars
=+SEM.
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DISCUSSION
In this study, we addressed the hypothesis that age-related changes in lymph node stromal cells
could be an underlying factor hindering T cell immunity to influenza infection in aged mice. These
experiments provide the most comprehensive analysis of aged lymph node stromal cells to date.
We determined that the number of stromal cells in young and aged MLNs at homeostasis is
similar, but aged lymph nodes have decreased concentrations of CCL19 and CCL21, which
correlate with impaired T cell homing into the lymph node. These results contradict those in the
literature with regards to how aging impacts the number lymph node stromal cells. Several reports
have stated that aged lymph nodes either have fewer FRCs or total stromal cells32–34, but these
decreases may be technical artifacts due to poor digestion techniques. Stromal cell digestion
techniques are technically challenging and need to be optimized before reliable results can be
obtained20. Importantly we found that aged lymph nodes take five to ten minutes longer to digest
then young lymph nodes. The published data so far was from lymph nodes digested for the same
period of time and which may have under digested the aged compared to young lymph nodes.
Although unlikely, it is also possible that MLNs and PLNs analyzed in this study, may age
differently than cervical, inguinal, axillary and brachial lymph nodes analyzed by others32–34.

After antigenic challenge or infection, lymph node stromal cells expand and proliferate13,21,26. Here
we determined that aged stromal cells have different kinetics of expansion compared to young
after influenza infection. The peak of LEC and FRC expansion in aged MLNs is delayed compared
to young MLNs, in part due to decreased proliferation. BECs in aged MLNs have similar expansion
kinetics, but are actually increased in number in aged MLNs at day 12 post infection. The
biological importance of stromal cell expansion is unclear, since there is currently no way to
selectively inhibit their proliferation. Yet expansion of stromal cells is thought to be critical to
hypertrophy and resolution of lymph nodes and provide additional space for the immune response
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to occur14. What impact the altered expansion of stromal cell kinetics has on the immune response
to influenza is unclear. FRCs were shown to be critical for the initiation of adaptive immunity to
influenza infection, but when depleted after the immune response was initiated, adaptive immunity
developed unhindered21. It is possible that decreased numbers of FRCs and LECs at day 10 post
infection, may alter the formation of memory responses in aged mice, by decreasing the entry
new cells into the lymph node late during the immune response, which may differentiate into
memory45. In fact, it is well established that aged memory CD8+ T cells have reduced functionality,
and stromal cells may contribute to this problem46. It remains to be determined why aged FRCs
and LECs have delayed proliferation after influenza infection. Further studies are required to
elucidate the exact signals required for FRC and LEC proliferation.

Out of the lymph node stromal cell subsets, T cells have the longest potential for interaction with
FRCs, since they are the conduit upon which T cells traffic24. Morphologically we found that the T
cell zone FRC network remains intact with age and influenza infection. Like previous reports we
found that after infection, the density of the FRC network decreases, which may be in part due to
relaxation of the FRC network tension37. It remains to be determined if aged FRCs localization is
altered and if they extend into the B cell follicles of aged lymph nodes to contribute to architectural
disorganization found in aged lymph nodes. We found that the FRC produced chemokine CCL21
does not appear to extend into the B cell follicles of aged mice, so this may not be the case for
aged FRCs.

FRCs also are known to control proliferation of activated T cells via production NO29. We
demonstrated that young influenza specific CD8+ T cells had reduced proliferation in aged MLNs
and tested the hypothesis that aged FRCs may be the cells blocking this proliferation. Interestingly
we showed that is most likely not the case, with young and aged FRCs have similar inhibitory

120

capacity and production of NO. In vivo studies linking FRCs to T cell proliferation suppression
have used models of self-reactivity and whether or not this mechanism is important during viral
infections is unclear. We determined that after influenza infection, FRCs in young and aged MLNs
upregulate expression of NOS2, correlating with our in vitro results showing preserved
suppressive functionality. This data also presents the possible role of FRC mediated T cell
proliferation control during influenza infection. Why young T cells are not proliferating as well in
aged lymph nodes remains to be determined as well. Most likely numerous factors contribute to
this deficit including changes in the priming capacity of aged dendritic cells.

These data expand our picture of the aged immune system and elucidate possible roles of age
related changes in stromal cells to alterations in adaptive immune function. This is just the
beginning to our understanding of the impact of stromal cells on the aged immune response.
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CHAPTER 5
Discussion

The immune system is like a complex and elegant machine. When all of the components are fully
operative, the system functions properly, protecting the host from disease. When one cog
malfunctions, compensatory mechanisms can often overcome the deficit. Occasionally this is not
the circumstance and a singular problem can cause cascading downstream effects. In the case
of the aged immune system, with many broken or damaged gears, it becomes incredibly difficult
to track which parts are the mediators of the problem and which are simply downstream
consequences. Only by increasing our understanding of what changes are occurring in the aged
immune system we can begin to dissect causality and consequences.
Although descriptive in nature, this thesis progresses our understanding of the aged immune
system and provides important insight into how it responds to influenza infection. To model aging,
we used a widely accepted biomedical research model of humans, the of C57BL/6 mouse. Not
surprisingly, laboratory mice have a much shorter lifespan (about 24 months1) than the average
U.S. citizen (78.8 years2). Mice reach sexual maturity and are analogous to human adults
beginning at eight to 12 weeks of age3. Mice are considered aged or elderly starting at roughly 18
months4. One problem that is becoming more widely accepted and published in the immunology
community with the laboratory mouse model is cleanliness5. Laboratory mice, including mice used
for aging research, live in specific pathogen free (SPF) conditions, thus they are not exposed to
a pathogen until an experiment is performed. This lack of pathogen exposure has been show to
alter the functionality of the immune system, putting into question the ability of SPF mice to
adequately represent the human immune system6. Exposure to chronic pathogens like
cytomegalovirus (CMV) has been shown to dramatically alter immune system function and is
neglected in SPF mice models7. Several groups are working to create mouse pathogen exposure
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cocktails and models to more adequately represent the human immune system5,6,8. Such models
could potentially be applied to the aging mouse model to enhance it clinical relevance.
Although, immunologically the C57BL/6 mouse is a powerful tool, due to the tetramer reagents
and TCR transgenic strains available on the background9, it has the shortcoming of being inbreed
thus lacking genetic diversity. Several mouse models exist that recapitulate human genetic
diversity such as diversity outbreed mice, collaborative cross mice and four-way cross mice10–12.
Although not used in this thesis, several groups are currently using these models in aging
systems4,10. Despite the imperfections of the mouse model used in this thesis it is still a widely
accepted method and good starting point for studying the aged immune system. Other more
complex models may be used in the future to replicate these studies and enhance their validity.
In this thesis, we expand our understanding of how aging impacts multiple components of the
immune response to influenza infection, an often lethal problem for the elderly population 2. In
chapter two we start by characterizing how changes in CD4+ T cells may contribute to impaired
humoral immunity to influenza infection13. Our hypothesis predicted that alterations in CD4+ T
cells may contribute to impaired B cell immunity during influenza infection. Before these studies
were performed, it was unclear how aging impacted the maturation and function of TFH, the CD4+
T cell subset most intimately involved in B cell immunity. Yet it was well established that CD4+ T
cells had intrinsic defects that could potentially make them poor B cell helpers, including reduced
upregulation of the important costimulatory molecule CD154 (CD40-L)14. We found that young
and aged mice have equal numbers of influenza NP-specific CD4+ T cells after influenza infection
in their spleens, but fewer of these mature into germinal center TFH in aged mice. The NP-specific
TFH cells in aged mice also had altered costimulatory molecule expression and presented an
inhibitory phenotype with increased expression of IL-10 but not PD-1. Upon further analysis, we
found that more of the influenza NP-specific CD4+ T cells in aged mice were either regulatory T
cells or TFR at later time points after infection. From transfer experiments, we concluded that
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increased active TGF-β in the aged splenic environment may be driving the accumulation of
regulatory T cells, but not TFR, in aged mice. Sage et al used an NP-OVA in CFA immunization
model and had similar findings with increased TFR in aged mice when compared to young. From
in vitro experiments, this study also found that aged TFR were potent suppressors of B cell function
and that aged TFH were poor promoters of B cell immunity15. Previously we showed that aged
CD4 TCR transgenic cells transferred into young CD4 KO host and immunized with their cognate
antigen supported the development of a significantly weaker germinal center response compared
to young CD4+ T cells14. In chapter two, we carried out a similar experiment, but we transferred
a high frequency of young polyclonal CD4+ T cells into young and aged hosts then infected the
mice with influenza. We found that the young T cells in the aged host enhance the germinal center
B cell responses, showing that some of the B cell defects can be overcame in the presence of
sufficient CD4+ T cell help.
These findings present multiple targets that could be used to enhance immunity in the elderly. If
TFH development was enhanced it could potentially boost antibody mediated responses in the
elderly. One way that this can be accomplished in response to vaccination, is increasing the dose
of antigen used in the vaccination, since TFH responses are proportional to the quantity of antigen
available16. This approach has shown promising results for influenza vaccination in the elderly.
High dose Fluzone vaccination was shown to be 24.4% more effective at preventing influenza in
the elderly population over the age of 65 when compared to a standard dose influenza vaccine
17

. Another possible method of boosting immunity in the elderly would be by blocking inhibitory

responses including the development of T regs.
One potential method to decrease regulatory T cell formation would be to deplete TGF-β, since it
is an important factor in the development of peripheral T regs18. This may enhance immunity, but
it is possible that this may also result in unwanted autoimmune reactions if too much TGF-β is
depleted. TGF-β KO mice die of autoimmunity by the age of three to four weeks, but targeted low
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level depletion may have the potential to be therapeutically effective19. It also remains to be
determined which cells are the source of the increased TGF-β in the aged splenic environment
from our studies. Future studies will need to be performed to answer this question.
Another factor which we did not explore that may be contributing to impaired germinal center
formation in response to influenza is changes in follicular dendritic cells with aging. It has been
shown that aged FDCs have impaired antigen trapping, and disorganized morphology20–22 which
may contribute to smaller disrupted germinal centers found in aged mice. Known changes in
FDCs, a type of stromal cell, led us to hypothesize that other stromal cell populations in the spleen
may be altered with age.
In chapter three, we characterize how aging impacts FRCs in young and aged spleens at
homeostasis. FRCs are stromal cells in the T cell zone of the spleen, which are important conduits
of immune cells and antigen into the white pulp23. FRC produced CCL19 and CCL21 are important
chemotactic signals for the recruitment of responding immune cells into the T cell zone of the
white pulp24,25. We have previously shown that aged spleens, after I.P. immunization with OVA
and alum, had decreased concentrations of CCL19 and CCL21 compared to young spleens26.
Homeostatic chemokine concentrations have been reported to dip after immune challenge 27, so
the decreased concentration in aged spleens after challenge may not have been indicative of
what was happening at homeostasis. Decreased homeostatic chemokines in aged spleens
correlated with reduced homing of young OTII TCR transgenic CD4+ T cells into aged spleens
after challenge. Fewer of the young OTII cells in the aged spleens were recruited into the T cell
zones of the spleens, which correlated with diffuse localization of CCL2126. Although this study
indirectly suggested FRCs may be altered in the spleens of aged mice, it did not directly examine
them, which we did in chapter 3. Another study by Aw et all used confocal microscopy to quantify
splenic FRCs and showed increased FRC area in aged spleens at homeostasis, but their data
had high variability and did not quantify number of FRCs using flow cytometry28. Thus, prior to
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our current study, there was little information in the literature about how aging impacts splenic
FRCs.
We found, by employing flow cytometry and confocal microscopy, that aged spleens had reduced
FRCs compared to young spleens, which correlated with reduced homeostatic chemokine
concentrations and homing of young T cells. Unlike our previous publication, we found that CCL21
only marginally extended into the B cell follicles of aged mice26. Architectural disruption of splenic
white pulp and CCL21 localization may become more diffuse after activation in aged spleens. We
only noted mild merging of the T cell zone and B cell follicles in naïve spleens, whereas after
influenza infection, as shown in chapter two, B cell follicles are considerably more disorganized13.
This disruption may be due to altered chemokine production by stromal cells or it could be due to
defects in chemokine receptor expression or sensing in lymphocytes, but this remains to be
determined.
These changes could have the potential to delay immune response formation in aged spleens.
Disruption of splenic architecture could potentially increase the time it takes for immune cells to
find each other and interact. Delayed entry into the spleen could also increase the time it takes
for the rare naïve T cell to find the dendritic cell presenting its cognate antigen. Importantly, T
cells transferred into mice deficient in CCL19 and CCL21 have also been shown to have reduced
velocity, which could further impact potential interactions with dendritic cells29. Thus, the decrease
in these chemokines with aging could potentially reduce T-DC interactions and T cell speed, which
may increase the time necessary for immune responses to initiate.
Many aspects of splenic FRC biology remain to be elucidated. Basic questions such as if FRCs
proliferate in the spleen after immune challenge or infection are still unanswered. It is even unclear
if lymph node and splenic FRCs are of the same origin. Future studies can be performed to answer
these basic questions. The field of lymph node FRC biology is much more advanced than its
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splenic counterpart and, thus, in chapter four we sought to determine if changes in lymph node
stromal cells were an underlying factor in impaired T cell immunity to influenza infection in aged
mice.
Our hypothesis predicted that changes in aged FRC functionality, including increased inhibitory
capacity, could contribute the impaired formation of robust T cell responses in aged mice to
influenza infection. We also sought to answer some basic questions to address if aging impacts
the number of FRCs, LECs and BECs at homeostasis and after influenza infection. Within the
past two years, three studies have been published that attempt to quantify the number of stromal
cells in aged lymph nodes at homeostasis30–32. All three of these studies employed lymph node
digestion protocols that may have skewed their results. Davies et al. claimed that there were fewer
total stromal cells in aged cervical lymph nodes, mainly due to fewer DNCs in aged lymph nodes31.
Turner et al. found that aged lymph nodes (pooled cervical, axillary, brachial and inguinal) had
fewer DNCs, but equal numbers of FRCs, LECs and BECs30. The last published study by
Becklund et al claimed that there are fewer FRCs in aged compared to young lymph nodes at
homeostasis but failed to perform statistical analysis to support their result32. After several months
of optimization, we were able to digest young and aged lymph nodes with high viability and
reproducibility.
To further validate the reproducibility of our lymph node digestions, we digested both draining and
non-draining lymph nodes during influenza infection, with the idea that non-draining lymph node
stromal cell numbers should not change during the course of infection and would be a way to
monitor variability in digestions. We determined that there were no significant differences in the
number of total stromal cells, FRCs, LECs or BECs in MLNs or PLNs at homeostasis. Interestingly
after influenza infection we found that aged MLNs had fewer total stromal cells, FRCs and LECs
at day ten, a previously reported peak33. The number of FRCs and LECs in aged MLNs reached
that of young mice by day 12 post infection, showing a delayed response. The number of BECs
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was equal at day ten post infection but higher at day 12 post infection in aged lymph nodes. We
also determined that reduced proliferation, but not increased death may contribute to decreased
FRC and LECs numbers at day ten post infection. The exact signals responsible for stromal cell
proliferation are currently unclear. We tried to repeat several methods reported in the literature to
get aged FRCs to proliferate after influenza infection and failed to repeat what was published
(data not shown)34–36. Future studies need to be performed to uncover the exact signals required
for proliferation. Another possible mechanism by which FRCs can increase in number during an
immune response is by the recruitment of precursor cells from adipose tissue37,38. It remains to
be determined how aging impacts FRC precursors in adipose and if they have impaired migration
into MLNs after infection. This could be a contributing factor in the reduced number of FRCs at
day ten post influenza infection in aged mice. The physiological consequences for altered stromal
cell proliferation kinetics are unclear, since there is currently no way of specifically blocking
stromal cell proliferation during infection or antigenic challenge. Studies using mouse models to
conditional deplete FRCs have shown that they are required at the start of the immune response
to influenza infection to make a strong adaptive immune response. Once the response has been
initiated, FRCs can be depleted without hindering adaptive immunity33. We hypothesize that
altered stromal cell proliferation kinetics may possibly not have impact on the primary response
to influenza, but may actually be a factor contributing to impaired memory T responses in aged
mice39. Fewer FRCs could reduce the recruitment of naïve T cells into aged lymph nodes late
during the immune response, which is important since it has been reported that “latecomer” T
cells are more prone to becoming memory cells40. Further studies will need to be completed to
test this hypothesis.
Since T cells have the greatest potential to interact with FRCs due to their location in the lymph
node, we sought to further characterize FRC morphology and function in aged mice. Our
hypothesis predicted that the FRC network in aged lymph nodes may be more disconnected,
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which could potentially impair the ability of T cells and dendritic cells to locate each other in the
lymph node and delay T cell responses in aged mice41. This was in fact not the case, we found
that the T cell zone FRC network was similar in young and aged MLNs at steady state and during
influenza infection. It should be noted that our analysis of FRCs was limited to the T cell zone and
there may be age related changes in FRC morphology in the medulla or near B cell follicles, which
could be determined with further imaging studies. Extension of FRCs into the B cell follicles could
be a contributing factor to the altered B cell follicle morphology in aged lymph nodes. We did
determine that the FRC produced chemokine CCL21 did not appear localized in the B cell follicles
of aged MLN, so extension of FRCs into the B cell follicle is probably not occurring with aging.
Aged MLNs did have decreased concentrations of CCL19 and CCL21, which correlated with
decreased recruitment of young naïve transferred T cells. After infection, the concentration of
CCL21 dipped in young lymph nodes, but not aged lymph nodes, suggesting that the ability of
aged FRCs to respond to challenge is reduced27. Muller et al. showed that CD4+ T cells and
interferon gamma were required for FRCs to decrease their expression of CCL21 during immune
challenge27. It is possible that there may be reduced levels of interferon gamma or CD4+ T cells
in aged lymph nodes, which may provide inadequate signals for aged FRCs to down regulate
expression of CCL21. This mechanism needs additional studies to be determined.
Another factor that may contribute to the reduced recruitment of young T cells into aged lymph
nodes are HEVs. HEVs are the entry sites for lymphocytes into lymph nodes and alterations in
these vessels may impair T cell entering42. We found that HEVs in aged lymph nodes were thinner
in morphology but expressed similar levels of ICAM-1, which is needed for T cell entry. Whether
the altered morphology of aged HEVs contributes to reduced T cell homing remains to be
determined. The ability of young T cells to traffic though aged HEVs could be analyzed in vivo
using intra-vital microscopy, which could determine the time it takes for T cells to pass through
HEVs. Our imaging data is just the start to understanding how HEVs age.
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We next hypothesized that FRCs could have increased inhibitory capacity and be a factor in the
impaired T cell responses to influenza infection. FRCs have the capacity to reduce T cell
proliferation via production NO43. Similar to previous studies using other models26, we found that
young influenza specific CD8+ T cells transferred into aged mice had reduced proliferation in
aged MLNs after influenza infection when compared to young MLNs. We first used an in vitro
method developed by Lukacs-Kornek at el. to see if FRCs contributed to this reduced
proliferation43. Our in vitro studies determined that FRCs from both young and aged mice had a
similar capacity to inhibit T cell proliferation, with similar production of NO. In vivo we found that
FRCs in young and aged MLNs upregulate expression of NOS2 equally after influenza infection.
This outcome correlated with our in vitro results which suggested that aged FRCs maintain their
suppressive capacity. There are of course limitations to these studies. The in vitro experiments
could potentially select for FRCs in aged lymph nodes with a more functional phenotype,
especially since they are grown in culture for six days. We tried to directly isolate FRCs from mice
and co-culture them with CD8+ T cells and stimulation, but found that the digestion was too rough
on the FRCs and they did not inhibit T cell proliferation with many of them dying in culture (data
not shown). Our in vitro data is only correlative as well. Currently there are no mouse models
available to conditionally deplete NOS2 in FRCs, which could be used during infection to
determine if T cell proliferation was altered in the absence of NOS2. There are inhibitors of NOS2
available, but if used in vivo they could block NOS2 expression in other immune cells like
macrophages and neutrophils and influence the course of infection44. Of note, this is the first time
that in either young or aged mice that NOS2 expression has been examined during the course of
influenza infection in FRCs. LECs also have the ability to suppress the proliferation of activated T
cells and it remains to be determined if changes in aged LECs could contribute to reduced
proliferation of T cells in aged lymph nodes.
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Multiple other factors may contribute to the reduced proliferation of young T cells in aged lymph
nodes after influenza. Regulatory T cells are increased in aged mice and could be impairing T cell
proliferation45–48. Changes in the ability of aged dendritic cells to prime young T cells could also
contribute to impaired proliferation. Several studies have shown that in vitro, aged dendritic cells
are capable of priming young T cells with the same efficiency as young dendritic cells49,50.
Additional studies are needed to determine how aging impacts dendritic cell responses to
influenza infection and to determine the mechanism behind this impaired T cell proliferation.
Although it appears as though FRCs are not directly blocking T cell proliferation, they may be an
underlying factor in other age related problems, such as autoimmunity51. FRCs have been shown
to have a role in mediating peripheral tolerance via expression of deformed epidermal
autoregulatory factor 1 homologue, which allows FRCs to express self antigens 52. FRC
expression of tissue restricted antigens allows for the depletion of autoreactive T cells which may
be involved in the development of autoimmunity53,54. Additional studies are required to determine
if aging alters this functional ability of FRCs. Multiple other aspects of the immune response
including maintenance of T cell homeostasis could also be influenced by age related changes
FRCs55.
Since the studies in this thesis are the first to examine in depth how aging impacts lymph node
stromal cells, many questions remain to be answered. Since stromal cells are just beginning to
be appreciated for their role in immune responses, it is not surprising that many aspects of their
biology remain to be elucidated. This research has laid the ground work for others to further
characterize and test stromal cells as a factor in aged related immune impairment.
Although the picture is still incomplete, the research in this thesis has significantly progressed our
understanding of the age immune response to influenza infection. This thesis has progressed our
understanding of how aging impacts TFH, TFR, T reg, germinal center, FRCs, LECs, BECs, and
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HEV responses at steady state and influenza infection. These studies are the foundation for the
development of future treatments that could help the lives of countless elderly people.
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